Biofilm and planktonic lifestyles of Porphyromonas gingivalis and Fusobacterium nucleatum. Proteomic analysis of bacteria grown as planktonic cells, mono- and dual species biofilm, and characterization of the biofilm extracellular polymeric matrix’ by Mohammed, Marwan
Biofilm and planktonic lifestyles
of Porphyromonas gingivalis and
Fusobacterium nucleatum
Proteomic analysis of bacteria grown as planktonic cells, mono- and dual 
species biofilm, and characterization of the biofilm extracellular polymeric 
matrix’
Marwan Mansoor Ali Mohammed
University of Bergen, Norway
2018
Thesis for the Degree of Philosophiae Doctor (PhD)
at the University of Bergen
Avhandling for graden philosophiae doctor (ph.d )
ved Universitetet i ergen
.
2017
Dato for disputas: 1111
Biofilm and planktonic lifestyles of
Porphyromonas gingivalis and
Fusobacterium nucleatum
Proteomic analysis of bacteria grown as planktonic cells, 
mono- and dual species biofilm, and characterization of the 
biofilm extracellular polymeric matrix
Marwan Mansoor Ali Mohammed
2018
Thesis for the De ree of Philosophiae Doctor (PhD)
Date of defence: 06.04.2018




© Copyright Marwan Mansoor Ali Mohammed
Name:
Year: 2018
Biofilm and planktonic lifestyles of Porphyromonas gingivalis and 
Marwan Mansoor Ali Mohammed
Skipnes Kommunikasjon / University of Bergen
 3 
Abbreviations 
ATP          Adenosine triphosphate 
Bap          Biofilm associated protein 
CDC          Centers for Disease Control and Prevention 
CFU          Colony Forming Unit 
CLSM         Confocal Laser Scanning Microscopy 
DAVID       Database for Annotation, Visualization and Integrated Discovery 
DNA          Deoxyribonucleic Acid 
eDNA          Extracellular Deoxyribonucleic Acid 
EPH          Ecological Plaque Hypothesis 
EPM          Extracellular Polymeric Matrix 
EPS          Extracellular Polymeric Substances  
FAA           Fastidious Anaerobic Agar 
FASP           Filter Aided Sample Preparation 
LC-MS         Liquid chromatography-mass spectrometry  
LFQ           Label-Free Quantification 
LPS           Lipopolysaccharide 
NSPH           Non-Specific Plaque Hypothesis 
OD           Optical Density 
OMVs Outer Membrane Vesicles 
PBS            Phosphate Buffered Saline 
PSD            Polymicrobial Synergy and Dysbiosis  
SPH            Specific Plaque Hypothesis 
 4 
Scientific environment  
 
The following doctoral work including all laboratory work in this study were 
conducted at the Faculty of Medicine, University of Bergen, Bergen, Norway. 
 
Laboratory experiments 
Section for Microbiology and Immunology 
Department of Clinical Science   
 
Proteomics  
The Proteomics Unit at the University of Bergen (PROBE) 
The Department of Biomedicine 
 
Course and administrative work 
Department of Clinical Science   







The present study was conducted in the Department of Clinical Science and the Centre for 
International Health – Faculty of Medicine, University of Bergen. The study was supported 
by the Norwegian State Educational Loan Fund through the Quota scholarship program.  
 
 All thanks and praise to the Almighty God for giving me patience and strength to overcome 
all difficulties in this long and unforgettable journey and for putting in my way people 
without whose help, support and encouragement this work would not have been reached to 
an end. 
 
I would like to express my heartfelt gratitude to my main supervisor Professor Vidar 
Bakken and my co-supervisors Professor Audun H. Nerland and Associate professor 
Mohammed Al-haroni, for their continues invaluable expert guidance, patience and 
encouragement throughout this journey. 
Special thanks also to my co-authors, Postdoc Veronika Kuchařová Pettersen and 
Professor Harald G. Wiker for providing important contributions to this work.  
 
My special thanks also to my friend Associate Professor Nezar Al-hebshi for helping me to 
get the opportunity to study at the University of Bergen and for their continued support 
during the study time. 
 
Thanks also goes to the staff of oral microbiology lab and the staff at 5th floor of the 
laboratory building for creating such a positive work environment, with special thanks to the 
previous excellent technician Øyunn Nilsen, who taught me most of the needed laboratory 
techniques in the beginning of my research career.  
 6 
I also thank the staff of the Molecular Imaging Center (MIC) and The Proteomics Unit at the 
University of Bergen (PROBE) for kind help and guidance during my use of the two 
facilities. 
I thank also the staff at the University of Science and Technology Dental College in Sanaa, 
for their encouragement and support. 
 
I would like to thank all my study colleagues, friends in Bergen, my neighbors in Fantoft, all 
Sudanese and Yemeni friends for the nice social activities and for their support during my 
stay here in Bergen, the words will not be enough to show my deepest gratitude.  
Finally, I wish to express my deepest gratitude to my family, to the soul of my father in his 
heavenly existence, to my mother Gamila Abdalmajid, to my sisters Nawal and Amna, to 
my brothers Salah, Ahmed, Abdulrahman and Mahmoud for all their inspiration, great 
love and constant support. I am endlessly grateful to my dear wife Ghadah Alaghbari and 
my lovely son Ayman and my beautiful daughter Aya for their love, patience, warmth, 









Periodontitis is one of the most prevalent infectious diseases affecting humans. 
Periodontitis leads to the destruction of the dental support tissues, which in the 
terminal stage causes loss of teeth. Periodontitis is biofilm related, a situation where 
several bacterial species are organized as a community whose resident species differ 
in many respects from their planktonic (free-living) counterparts. Fusobacterium 
nucleatum and Porphyromonas gingivalis are among the subgingival bacterial species 
that play a major role in the dental biofilm formation.  F. nucleatum acts as a bridge 
between early and late colonizers in the dental biofilm and coaggregates with almost 
all the species that are considered putative periodontal pathogens. P. gingivalis 
harbors many virulence factors that facilitate colonization and invasion of the 
periodontal epithelial lining. The main aim of this project was to study in depth and 
characterize in vitro a dual species biofilm composed of F. nucleatum and P. 
gingivalis using molecular imaging techniques and proteomics. Furthermore, we 
wanted to explore the extracellular polymeric substances in the biofilm matrix of the 
dual and mono-species biofilm, followed by protein identification and analysis of 
their differential expression.  
        Our results show that proteins and carbohydrates are the major components of 
the biofilm matrix, and that extracellular (eDNA) is also present. The matrix 
components are also shown to vary among the species. Proteinase K enzyme showed 
no effect on the concentration of the eDNA or carbohydrate isolated from the treated 
matrices. DNase I and proteinase K enzymes had no significant effect on biofilm 
formation or on mature biofilms under the conditions studied. In the flow-cell biofilm 
model, F. nucleatum was able to grow in partially oxygenated conditions while P. 
gingivalis failed to form a biofilm alone under similar conditions but it can grow with 
F. nucleatum as a dual species biofilm. 
                We identified 542, 93 and 280 proteins from the matrices of F. nucleatum, 
P. gingivalis, and the dual-species biofilms, respectively. Nearly 70% of all matrix 
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proteins in the dual-species biofilm originated from F. nucleatum, and a majority of 
these were cytoplasmic proteins, suggesting enhanced lysis of F. nucleatum cells. The 
proteomic analysis also indicated an interaction between the two species: 22 F. 
nucleatum proteins showed differential levels between the mono and dual-species 
extracellular polymeric matrices (EPMs), and 11 proteins (8 and 3 from F. nucleatum 
and P. gingivalis, respectively) were exclusively detected in the dual-species EPM. 
Oxidoreductases and chaperones were among the most abundant proteins identified in 
all three EPMs. The biofilm matrices also contained several known and hypothetical 
virulence proteins, which can mediate adhesion to the host cells and disintegration of 
the periodontal tissues. 
                Comparisons between the protein profiles for the two bacterial species 
grown as a biofilm or in the planktonic state, and when grown as a mono- or dual-
species biofilm, showed significant differences between each setting examined. The 
most abundant proteins have function such as oxidoreductases, acyltransferases, outer 
membrane proteins and proteases. Several virulence factors were among the most 
abundant proteins in both biofilm and planktonic growth conditions. Vitamin B 
biosynthesis proteins were increased in the biofilm setting compared to the 
planktonic. When grown in dual species, P. gingivalis showed reduced protein levels 
in many functions including vitamin biosynthesis, nucleotide biosynthesis, lipid or 
fatty acid biosynthesis and translation and ribosomal process. These results indicated 
how growing in a community provides a favorable environment to P. gingivalis and 
reduces its stress. 
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1.1 Bacterial biofilm 
1.1.1 Biofilm mode of growth 
A biofilm has been defined as “an organized community of surface adherent 
microorganisms embedded in an external polymeric matrix” or as a “matrix-enclosed 
bacterial population adherent to each other and/or to surface or interface”. This 
definition includes microbial aggregates and floccules and also adherent populations 
within the pore spaces of porous media (1). Biofilms occur in a variety of places, from 
pipelines and ship bottoms to teeth. Biofilms develop in a four-stage process; the 
initial stage includes the attachment of planktonic microorganisms to the substratum 
(Fig. 1). This is followed by bacterial growth, and cell division which leads to the 
colonization of the surrounding area (irreversible attachment), followed by external 
matrix production and formation of the biofilm (maturation) (2). These three stages 
are followed by the final stage of biofilm development which is the detachment of 
cells from the biofilm and their dispersal into the environment (3). Bacteria do not act 
individually to form biofilms, but co-aggregate to help initiate the early stages of 
biofilm formation. The regulation of gene expression in response to this local 
accumulation of large numbers of bacteria is recognized as quorum sensing (4). With 
quorum sensing, a population of unicellular organisms can synchronize the production 
of virulence factors for shared defense, or of colonization factors for symbiotic 
interaction with the host (4). Following the initial adhesion, adherent cells begin to 
change their original pattern of gene expression to their biofilm phenotype, and the 
secretion of polysaccharides and other matrix components transform their physical 
connection to the surface and to each other. Surfaces may in turn influence the 
resultant microbial communities, if they contain insoluble nutrients (e.g., cellulose) or 
reduced metal salts, because the biofilms will produce high local concentrations of 
enzymes and shuttle molecules to mobilize this energy (5). 
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 The mature biofilm is a complex heterogeneous structure of dormant and actively 
growing bacterial colonies along with further enzymes, excretory products and small 
channels forming part of the overall structure. The major features that distinguish 
biofilm forming bacteria from their planktonic counterparts are their surface 
attachment ability, high population density, extracellular polymeric substances (EPS) 
and a wide range of physical, metabolic and chemical heterogeneities (6). 
 
Figure 1. Diagram showing the development of a biofilm as a four-stage process. Stage 1: initial 
attachment of cells to the surface. Stage 2: production of the extracellular polymeric substance. Stage 
3: maturation of biofilm architecture. Stage 4: dispersion of single cells from the biofilm. Detached 
cells disseminate and adhere elsewhere to start new biofilm if conditions are suitable. Adopted from 
(7).  
It is now recognized that biofilm formation is an important aspect of many diseases, 
including endocarditis, osteomyelitis, dental caries, middle ear infections, medical 
device-related infections, ocular implant infections, and chronic lung infections in 
cystic fibrosis patients (8).  According to the CDC, 65% of all infections in developed 
countries are caused by microbial biofilms (9). Biofilms can tolerate antimicrobial 
agents at concentrations of 10–1000 times more than that needed to eradicate 
genetically equivalent planktonic bacteria (10, 11). They are also very resistant to 
phagocytosis, making biofilms extremely difficult to eradicate from living hosts (9).  
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1.1.2 Extracellular polymeric substances 
All biofilms share several common features including the production of EPS, which 
makes up the major constituent of biofilm other than the bacterial cells. In general, it 
is estimated that the microorganisms account for less than 10% of the dry weight of 
the biofilms, whereas the matrix can account for more than 90% (12). EPS are 
hydrated biopolymers secreted by bacteria that surround and immobilize microbial 
aggregates, leading to the macroscopic appearance of biofilms, which are frequently 
referred to as ‘slime’(12). The matrix increases resistance to host defenses and 
antimicrobial agents, compared with the more vulnerable; free-floating cells, and it 
forms a hydrated barrier between cells and their external environment. The functions 
of the matrix include adhesion, aggregation of microbial cells, cohesion of biofilm, 
retention of water, absorption of organic and inorganic material, enzymatic activity, 
nutrient source, exchange of genetic information, and export of cell components (12). 
The EPS are chemically complex and can vary significantly between biofilms, 
depending on the microorganisms present, the shear forces experienced, the 
temperature and the accessibility of nutrients. EPS were initially called ‘extracellular 
polysaccharides’ but were renamed, as it became clear that the matrix also contains 
proteins (Fig. 2), nucleic acids, lipids and other biopolymers such as humic substances 
(12). 
Biofilms of different origins have been found to contain extracellular DNA (eDNA), 
but it was reported to occur in particularly large amounts in waste-water biofilms and 
recent studies indicate that eDNA plays an important role in the establishment of  S. 




Figure 2. Representative CLSM image showing proteins in EPM of 24 h dual species biofilm 
(Fusobacterium nucleatum ATCC 25586 and Porphyromonas gingivalis W50) grown in flow cells. The 
proteins were stained with SYPRO® Ruby stain (blue). (Source: Marwan M A Mohammed). 
 
1.2 Biofilm dispersion  
The extracellular polymeric substances can be considered as a house for the biofilm 
cells (15). Biofilm dispersal can be defined as a mode of biofilm detachment with 
mechanisms that cause individual cells to separate from the biofilm and return to 
planktonic life (16). The mechanisms of biofilm dispersal can be active or passive (3). 
Active dispersal refers to mechanisms that are initiated by the bacteria, whereas 
passive dispersal refers to biofilm cell detachment that is mediated by external factors 
such as fluid shear, abrasion, predator grazing, and human intervention (3). Promoting 
detachment by the use of substances to induce biofilm removal directly by destroying 
the physical integrity of the biofilm matrix became an alternative for both medical and 
industrial applications where complete biofilm removal is essential (17). These 
substances (enzymes) can be also used in research that deals with the extraction of 
EPS components, enabling good separation for the components of the EPS to 
facilitate further investigations on these molecules (18).  
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1.2.1 Biofilm matrix-dispersing enzymes 
The increase in the prevalence of antibiotic resistance has made the use of 
antimicrobial enzymes in the disruption of bacterial biofilm formation an area of  
intense exploration (19). Production of extracellular enzymes that degrade adhesive 
components in the biofilm matrix is the basic mechanism of biofilm dispersal and the 
enzymes implicated in active biofilm dispersal include glycosidases, proteases, and 
deoxyribonucleases (DNase) (3) as shown in Table 1.  
It has been shown that eDNA is important for biofilm formation, and for providing 
adhesive support and protection of microbial cells in the biofilm (13, 20-22). 
Targeting eDNA in the biofilm matrix with enzymatic treatment therefore became an 
area of interest for many researchers, and a number of studies have now confirmed 
that different DNase enzymes can inhibit the formation of biofilms, or can disperse 
preformed biofilms, of many bacteria and fungi (23). Treatment of Escherichia coli 
and Staphylococcus aureus biofilms with DNase I displayed reduced biofilm biomass, 
total bacterial biomass, decreased the viability of bacteria, and decreased tolerance to 
antibiotics (24). Comparison has also been made of Acinetobacter baumanii, E. coli, 
Haemophilus influenza, Klebsiella pneumoniae, Pseudomonas aeruginosa, S. aureus 
and Streptococcus pyogenes treated with DNase I alone and combined with 
antibiotics. The use of antibiotics combined with DNase I resulted in a significant 
decrease in the established biofilm biomass compared to the reduction of biomass 
when each antibiotic or DNase I was used alone (25). Clinically, Dornase alfa 
(Pulmozyme, recombinant human DNAse 1, rhDNAse)  is an enzyme based product 
that has become one of the most commonly used medications to treat cystic fibrosis in 
the lung (26). 
 However, there are also several examples of biofilms that contain significant 
quantities of eDNA but are not dispersed by DNase enzymes (27-29). F. nucleatum 
and P. gingivalis biofilms are examples of biofilms that contain eDNA in their matrix 
but show no significant response when treated with DNase I (30).  
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Proteases also show anti-biofilm activity, because they degrade proteinaceous 
adhesins such as pili, fimbriae, and surface adhesins that are required for bacterial  
 
Table 1. Examples of the enzymes that can be used to disperse bacterial biofilms grouped according 
to the targeted structural components of the EPS. The table was prepared depending on these 
references (19, 31, 32). 
Enzyme type Examples  
Proteolytic enzymes Subtilisins, lysostaphin, bacteriophage lysins, proteinase 
K, protease A, papain, serratiopeptidase 
Polysaccharide-degrading enzymes Lysozymes, pectin methylesterase, alginate lysases, 
Dispersin B, amylases, N –glycanases, hyaluronidase 
DNA-degrading enzymes DNase I, restriction endonucleases, nuclease NucB, 
Dornase alpha 
Oxidative enzymes Glucose oxidase, hydrogen peroxide-responsive 
enzymes, lactoperoxidase 




cell-to-cell and cell-to-surface interactions (19). Proteinase K enzyme showed 
dispersal effect on S. aureus (33, 34). This effect was targeted to biofilm-associated 
protein (Bap), which has been reported to have a crucial role in the early stages of S. 
aureus biofilm development (34). On the other hand, oral bacterial biofilms of F. 
nucleatum and P. gingivalis were resistant to detachment by proteinase K even when 
tested at high concentrations (30). Interestingly, Rhodococcus ruber C208 bacteria 
respond with enhanced biofilm formation when treated with proteinase K, and the 
heat inactivated enzyme produces no effect (35). It may be hypothesized that in this 
bacteria, proteinase K degrades the self-secreted extracellular proteases responsible 
for the detachment process, suggesting that it may be necessary to tailor treatment 
specifically for different species or microorganisms (35).  
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Among the polysaccharide hydrolyzing enzymes; lysozymes, alginate lysases, 
Dispersin B and amylases are by far the most commonly used enzymes (19). One 
well-studied biofilm-matrix-degrading enzyme is Dispersin B, which is a 42-kDa 
bacterial a glycoside hydrolase produced by the periodontal pathogen Aggregatibacter 
actinomycetemcomitans (36). Dispersin B degrades poly-N-acetylglucosamine 
(PNAG), a biofilm matrix polysaccharide that facilitates attachment of A. 
actinomycetemcomitans to abiotic surfaces (3). Several studies showed the efficacy of 
this enzyme alone or combined with other materials in dispersing bacterial biofilms 
(37-40). 
Most dispersal studies have been done in vitro with mono-species biofilms. It is 
extremely difficult to generalize these results to any environmental biofilm, especially 
to a complex biofilm community like dental biofilm. While several potential 
dispersal-inducing agents have been identified, it remains to be seen whether any of 
these agents will have clinical significance (3). 
 
1.3 Oral biofilm 
1.3.1 Definition, structure and formation 
Dental plaque is a complex microbial biofilm (Fig. 3), and it is the key factor 
associated with the two main dental and oral diseases, dental caries and periodontal 
disease (41). Dental plaque was the earliest biofilm studied: it was explored in the 
seventeenth century by Antonie van Leeuwenhoek when he reported the diversity and 
high number of ‘animalcules’ present in ‘scrapings’ taken from around human teeth 
(42). It is defined clinically as the soft, tenacious deposit that forms on tooth surfaces 
that is not readily removed by rinsing with water (43). Microbiologically, it can be 
defined as the diverse community of microorganisms found on a tooth surface as a 
biofilm, embedded in an extracellular matrix of polymers from the host, and is of 
microbial origin (41).  
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Biofilm development in the oral cavity starts with the formation of acquired pellicle, 
which is a thin coating of salivary proteins that attach to the tooth surface within 
minutes after a professional cleaning. Microorganisms are then transported passively 
by salivary flow and attach to the outer surface of the pellicle by reversible and weak 
physicochemical forces (Van der Waals and electrostatic energy). The attachment 
becomes irreversible when the adhesins on the microbial surfaces interact with 
receptors on the acquired pellicle (adhesin-receptor interaction). 
 
 Figure 3. Spatiotemporal model of oral bacterial colonization, representing the initial 
colonizers binding to the complementary salivary receptors in the acquired pellicle, and the 
late colonizers and the bridging bacteria in-between. The model was proposed by 
Kolenbrander and London (44-46). Reprinted by permission of Nature Publishing Group.   
 
At this stage, the tooth's surface is colonized predominantly by Gram positive 
facultative cocci, primarily streptococcal species, followed by coaggregation/ 
coadhesion and microbial succession to form the mature biofilm with excessive 
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diversity and a slower mode of growth. Detachment from surfaces begins due to shear 
forces and can be attached or colonize elsewhere (47). 
 
1.3.2 Microbial interactions in biofilms 
The close proximity of the cells within a biofilm offers an ideal environment for cell-
to-cell interactions. These interactions occur through metabolic communication, 
which can be synergistic and thus beneficial to the involved population, or 
antagonistic. For example, the excretion of a metabolite by one organism can be used 
as a nutrient by a different organism, or the breakdown of a substrate by extracellular 
enzymatic activity of one organism may create biologically available substrates for 
different organisms (45). The exchange and metabolism of oxygen within the biofilm 
is another form of communication between different aerobic and obligate anaerobic 
species and plays an especially significant role for the survival of obligate anaerobes 
(48). 
Coaggregation is the physical interaction between bacteria of different species. It is 
not random among oral bacteria; each species binds specifically to other bacteria. 
Coaggregation interactions are believed to contribute to the development of biofilms 
by two routes. The first route is by single cells in suspension specifically recognizing 
and adhering to genetically distinct cells in the developing biofilm. The second route 
is by the prior coaggregation in suspension of secondary colonizers followed by the 
subsequent adhesion of this coaggregate to the developing biofilm. In both cases, 
bacterial cells in suspension (planktonic cells) specifically adhere to cells in the 
biofilm in a process known as coadhesion (49, 50).  
Another form of communication among oral bacteria in dental biofilm is cell-cell 
signaling whereby individual cells are able to communicate with, and respond to, 
neighboring cells by means of small, diffusible, effector molecules such as cell 
density dependent growth (quorum sensing) (47). The close proximity of the cells in 
the biofilm may also offer an excellent milieu for DNA exchange (gene transfer), as 
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the cells are in close juxtaposition and DNA can be trapped within the extracellular 
matrix (46, 47).  
In summary, the oral biofilm is associated with some of the most frequent chronic 
infections in humans (51) and it is among the first and most thoroughly studied 
biofilm causing infectious diseases. However, the diversity, complexity and 
multispecies nature of the oral biofilm makes further research imperative (52, 53). 
 
1.4 Periodontal diseases 
The periodontal diseases are a group of diseases characterized by inflammatory 
responses in the periodontium to bacterial accumulation on teeth adjacent to the 
gingiva (54).  According to the periodontal diseases classification that resulted from a 
1999 international workshop (55), diseases of the periodontium contains a long list of 
conditions involving the supporting structures of the tooth. The two most common 
and most investigated periodontal diseases are dental plaque–induced gingivitis and 
chronic periodontitis. Gingivitis is the simplest and reversible form of periodontal 
disease characterized by inflammation of the gingiva without destruction of the 
supporting tissues, while periodontitis is characterized by loss of the collagen 
periodontal attachment, loss of supporting alveolar bone and formation of deep 
periodontal pockets. Periodontal diseases are highly prevalent and can affect up to 
90% of the worldwide population and are considered to be the main cause of tooth 
loss in adults. Recently, there has been increasing interest in the relationship of 
periodontal disease to important systemic diseases such as cardiovascular disease, 
stroke, diabetes mellitus, pulmonary disease and complications in pregnancy (54, 56).  
The last 10 to 15 years have seen the emergence of several important new findings 
and concepts regarding the pathogenesis of periodontal diseases. These findings 
include the recognition of dental bacterial plaque as a biofilm, identification and 
characterization of genetic defects that predispose individuals to periodontitis, host-
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defense mechanisms implicated in periodontal tissue destruction, and the interaction 
of risk factors with the host defenses and bacterial plaque (57). 
 
1.5 Microbiology of periodontal disease 
There is wide agreement that microorganisms are the primary etiologic agents of 
various forms of periodontal disease. Particularly convincing data to support this 
came from the demonstrations by Löe and co-workers that removal of dental plaque 
by rigorous plaque control procedures or antiseptic agents could prevent or reverse 
clinical gingivitis in human volunteers (58-60).  
The search for the etiological agents of destructive periodontal disease has been in 
progress for over 100 years. However, until recently, there has been on-going 
controversy as to which bacteria within the biofilm are involved in the causation of 
these diseases. Two main hypotheses exist: the non-specific and specific plaque 
hypotheses (NSPH and SPH, respectively), first described by Loesche (1976). The 
NSPH considers the entire plaque flora as a producer of irritant products that, if 
exceeding the host detoxification threshold, result in slow tissue destruction (61). 
Consequently, treatment based on this hypothesis relies upon mechanical debridement 
of dental biofilm from the tooth surfaces for treatment and prevention; this non-
specific plaque mass reduction has been the paradigm of dental care for more than 
100 years (61, 62), but the NSPH failed to explain why certain individuals with 
longstanding plaque and gingivitis do not develop periodontitis. While the NSPH 
focuses on quantitative changes, the SPH focuses on qualitative changes, and states 
that only plaque with certain pathogens and/or a relative increase in levels of given 
indigenous plaque organisms causes infections. It was proposed that the treatment 
should be aimed at the diagnosis and then elimination of causative organisms, usually 
with an antimicrobial component. While there is evidence to support effectiveness of 
this approach from selective suppression of the microflora by chemotherapy using 
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both human and animal models, the current treatment paradigm dictated by the NSPH 
still predominates (63, 64). 
Some of the reasons for the uncertainty in defining periodontal pathogens were 
determined and described by Haffajee and Socransky in 1994, including: the 
complexity and diversity of the subgingival microbiota, difficulty obtaining a 
representative sample, difficulties in cultivation, characterization and identification of  
microorganisms in subgingival plaque, mixed infections, and opportunistic microbial 
species that may grow as a result of the disease, taking advantages of the conditions 
produced by the true pathogen, and periodicity of disease activity. Periodontal disease 
appears to progress with periods of exacerbation and remission. Ideally, a plaque 
sample should be taken at the peak of disease activity. Failure to detect the peak of 
activity may lead to an underestimate of the contribution of a pathogen(s) to a given 
lesion. Multiple periodontal diseases in different subjects that might not be 
differentiated on a clinical basis, thus, disease types may be misclassified and 
inappropriately pooled. Differences observed in clinical symptoms in different parts 
of the mouth may be explained by differences in levels of the pathogen or the stage of 
the destructive process. Disease might have occurred in shallow lesions due to one 
species and in deepening lesions by a succession of other species. Disease occurring 
in one site in the mouth could be due to an agent that is different from the one 
inducing destruction at a second site at the same time. Pathogens may be carried in 
low numbers in mouths that are free of destructive periodontal diseases (the so-called 
carrier state), making their role in disease more difficult to evaluate.  Strains of 
putative pathogens may differ in virulence. A virulent clonal type might be detected in 
periodontally healthy subjects, whereas non-virulent clonal types might be present in 
subjects with periodontal disease. An inability to distinguish virulent from non-
virulent clonal types would impede understanding.  It has been suggested that more 
virulent strains may harbour bacteriophages or plasmids. Bacterial plasmids are 
known to code for several virulence factors like invasiveness, adherence, and 
antimicrobial resistance as well as the production of toxins and noxious products (64). 
In light of these issues and after reviewing the literature, Haffajee and Socransky 
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pointed out some candidates as etiological factors of periodontal diseases (64).  They 
later came up with the color-coded system reflecting the cluster analysis, and they 
described them as microbial complexes (65). The red complex was the species that 
were strongly associated with periodontitis, followed to a lesser extent by organisms 
in the orange complex. The rest of the complexes show no association with 
periodontitis (65). 
The ecological plaque hypothesis (EPH) was proposed by Marsh in 1994. According 
to this hypothesis, the periodontal diseases are opportunistic endogenous infections 
resulting from a shift in the ecology of the plaque biofilm from a predominantly Gram 
positive facultatively anaerobic microflora to a Gram negative obligate anaerobic or 
micro-aerophilic flora, creating an anaerobic environment which helps their growth 
(66). Thus, any species in the dental biofilm may be pathogenic since ecological 
changes in the environment may favour the pathogenicity and virulence mechanisms 
for that particular organism (66, 67). Disease may thus be prevented by interruption of 
the environmental factors responsible for the ecological shifts as well as elimination 
of the putative pathogen (68, 69).  
Recently the concept of “Polymicrobial Synergy and Dysbiosis (PSD)” was proposed 
by Hajishengallis et al. (2012), which describes periodontitis initiation by a 
synergistic and dysbiotic microbiota, within which different members or specific gene 
combinations fulfill distinct roles that converge to shape and stabilize a disease 
provoking bacteria (70). The PSD concept was based on the keystone-pathogen 
hypothesis that states how low-abundance keystone species can disturb the tissue 
homeostasis through quantitative and qualitative changes to the commensal 
microbiota and orchestrate the inflammatory disease by remodelling a normal 
microbiota into a dysbiotic one (71). In a study on mice, it has been shown that P. 
gingivalis can impair innate immunity in ways that enhance the growth of the 
periodontal microbiota and change its composition (72). The keystone-pathogen P. 
gingivalis was present at low concentration levels (<0.01% of the total microbiota) 
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and still had the ability to remodel the symbiotic community into dysbiotic state that 
triggered inflammatory bone loss (72, 73). 
 
1.5.1 Porphyromonas gingivalis  
P. gingivalis is classified in the genus Porphyromonas, family Porphyromonadaceae, 
order Bacteroidales, class Bacteroides, phylum Bacteroidetes (74). The bacterium is  
non-motile, Gram negative, rod-shaped, anaerobic, asaccharolytic and highly 
proteolytic. P. gingivalis, which is often found in deep periodontal pockets of 
humans, produces a broad array of potential virulence factors involved in tissue 
colonization and destruction as well as host defense perturbation (75).  
After it was mentioned as member of the red complex (a group of three species 
including P.gingivalis, Trepomema denticola and Tannerella forsythia, which was 
strongly associated with each other and with periodontal disease site) and because it 
was the easiest of the three to grow and genetically manipulated, it became the most 
widely studied periodontal bacterium (70). 
P. gingivalis can locally invade the periodontal tissues and evade the host defense 
system by utilizing a panel of virulence factors that cause disruption in the immune 
and inflammatory reactions. The potential virulence factors of P. gingivalis have been 
extensively described in several reviews (75-78). These virulence properties include: 
 Ability to adhere to host cells followed by invasion or internalization via lipid 
rafts (79).  This asaccharolytic pathogen can survive and replicate within a 
vacuole utilizing the host proteins derived by autophagy. 
 Lipopolysaccharide (LPS) of P. gingivalis is a key factor in the development of 
periodontitis. It induces pro-inflammatory cytokines, such as interleukin-1 β 
(IL-1β), IL-6, and IL-8, which induce periodontal tissue destruction and 
disrupt the bone-remodeling process (80).  
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 Fimbriae in P. gingivalis seem to participate in many interactions between the 
bacterium and the host, as well as with other bacteria. There are two main 
types of fimbriae that can be expressed by this pathogen, the major fimbria 
(FimA) and the minor fimbria (Mfa) (81). 
 Hemagglutinins, which are involved in non-fimbrial adhesion of the 
microorganism to host cells and aid hemin acquisition, which is necessary for 
bacterial growth, from erythrocytes (82). 
 Proteinases, especially cysteine proteases are known to be the most important 
virulence factors since they are able to degrade the periodontal tissue and at the 
same time disrupt host defence mechanisms (83). Gingipain is the term 
describing the cysteine proteases of P. gingivalis. They are classified as either 
Arg-gingipain or Lys-gingipain according to where they cleave the polypeptide 
(either after arginine or lysine residues) (78). 
 Outer membrane vesicles (OMV) are usually involved in bacterial adherence, 
defense against host factors, and the delivery of a wide range of toxins (84, 
85). 
The extensive research on P. gingivalis leads lastly to consider it as a keystone-
pathogen in the periodontal biofilm, since even when available in  low abundance it 
plays a major supporting role for an entire ecological community (71). By 
destabilizing innate immune signaling including the crosstalk between complement 
and Toll-like receptors (TLR), P. gingivalis can impair host defenses in ways that 
alter the growth and development of the entire microbial community (86), thereby 
triggering a destructive change in the normally homeostatic relation with the host. 
Therefore, P. gingivalis orchestrates rather than directly causes inflammatory bone 
loss, which is largely mediated by commensals that under conditions of disrupted 
homeostasis have the potential to cause deregulated inflammation and disease (87). 
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1.5.2 Fusobacterium nucleatum 
F.nucleatum is the type species of the genus Fusobacterium, which belongs to the 
family Bacteriodaceae. Among the 13 species in this genus (88), F. nucleatum 
species are most frequently isolated from the oral cavity. The bacterium is an 
anaerobic, non-spore forming, non-motile Gram negative rod bacterium with fused 
ends (89). The heterogeneity of F. nucleatum is well known and four (or five) 
different subspecies of F. nucleatum have been proposed (90-93). The five described 
F. nucleatum subspecies are: nucleatum, vincentii, polymorphum, fusiforme and 
animalis (90, 91, 93). The taxonomy of F. nucleatum subspecies is still an open 
discussion, as Kook et al. (94) recently proposed that F. nucleatum subsp. fusiforme 
and F. nucleatum subsp. vincentii could be classified as a single subspecies . F. 
nucleatum subsp. vincentii was an early published name; therefore, F. nucleatum 
subsp. fusiforme proposed by Gharbia and Shah can be regarded as a later synonym of 
F. nucleatum subsp. vincentii proposed by Dzink et al. (94). 
F. nucleatum is typically considered a strict anaerobe, but it can tolerate up to 6% 
oxygen atmosphere (89), and it responds by physiological changes and increased 
pathogenicity to oxidative stress (95, 96). In addition, F. nucleatum shows more 
tolerance to aerobic conditions in a biofilm than in planktonic form (30, 97). Figure 4 
shows F. nucleatum grown in a flow-cell biofilm model in partially oxygenated 
condition. This capacity enables F. nucleatum to play a protective role to the obligate 
anaerobic species in both biofilm and planktonic phases of aerated, mixed cultures of 
oral bacteria. It has been proposed that this co-aggregation is the mechanism by which 
strict anaerobes, such as P. gingivalis, survive under aerobic conditions, due to the 
formation of microenvironments in which the facultative organisms mediated 
reducing conditions (98, 99). 
F. nucleatum has an excellent co-aggregating capacity with many bacterial species in 
the oral cavity (100). This capability allows F. nucleatum to work as a bridge or a 
central species in physical interaction between Gram positive partners which 
represent the early colonizers on the teeth surfaces and Gram negative partners which 
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are the late colonizers and mostly obligate anaerobic species (46). These strict 
anaerobes can also benefit from the capacity of F. nucleatum to adapt to and reduce 
an oxygenated environment as mentioned earlier (45, 99). 
 
 
Figure 4. 36 h old F. nucleatum biofilm grown in the flow-cell biofilm model and stained with Live/dead 
stain. (Source: Marwan M A Mohammed). 
 
In addition to the ability to coaggregrate with other bacterial cells, F. nucleatum can 
also adhere and invade cells, e.g. human gingival epithelial cells (HGEC), leading to 
increased production of the pro-inflammatory chemokine interleukin-8 (IL-8) by these 
cells (101). The bacteria also show the ability to enter other types of oral cells like 
gingival fibroblasts and periodontal ligament fibroblasts in vitro (102). This ability to 
adhere to and invade host cells has been demonstrated both in vitro and in vivo (101-
103). 
F. nucleatum can affect the host immune response of the host by adhering to 
lymphocytes and inducing apoptosis by Fap 2 outer membrane protein (104). Also, 
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the F. nucleatum immunosuppressive protein (FIP) is capable of suppressing human 
B- and T-cell responsiveness (105). 
Other potential virulence factors include endotoxins (89), stimulation of matrix 
metalloproteinase production (106) and outer membrane proteins (89). 
F. nucleatum isolates have a higher proportion and greater number in individuals with 
compromised periodontal tissues; in general, it continues to maintain its proportion in 
the periodontal flora as gingivitis progresses and as periodontitis develops. The cell 
mass of F. nucleatum increases as much as 10,000-fold, making it one of the most 
abundant anaerobic species in the disease sites (107). However, the definite role of F. 
nucleatum in periodontal disease pathogenesis is probably masked because the 
bacterium is also a common isolate in healthy individuals (108). In addition, virulence 
factors of F. nucleatum are less studied than those in other bacteria known to be 
etiological agents of periodontal diseases. 
F. nucleatum is also common in clinical infections of other body sites, including 
brain, lung, liver, pelvic, ovarian and kidney abscesses, blood, spinal fluid and 
intrauterine device infections and pleurisy (107).  The pathogenic role of F. 
nucleatum in otitis media, orofacial and skin infections, tonsillar abscesses, septic 
arthritis, and bacterial endocarditis has been documented (89, 109), and it has been 
recovered from a variety of infections in children (110).  
 
Recently, accumulated studies show that F. nucleatum is associated with colorectal 
carcinoma (CRC) (111, 112), and is involved in CRC pathogenesis of promoting 
cellular proliferation and invasion in human epithelium and CRC cell lines and to 
enhance the progression of OSCC and CRC in animal models (113-117). F. 
nucleatum protein FadA modulates E-cadherin and activates b-catenin signaling, 
leading to increased expression of transcription factors, oncogenes, Wnt genes, and 
inflammatory genes, as well as growth stimulation of CRC cells (113). A recent study 
on the association between bacteria and oral squamous cell carcinoma (OSCC) 
showed that F. nucleatum was the most significantly overrepresented species in the 
tumors followed by P. aeruginosa (118). Bacterial-cancer association may be a 
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promising approach for the early detection of cancer by the assessment of immune 
response to antigens of tumor-associated microbe (119). Antibody-based serological 
testing against cancer-associated microorganisms including Epstein–Barr virus, 
human papillomavirus and Helicobacter pylori has been used in the diagnosis of the 
infection and tumor screening (120, 121). 
 
1.5.3 Dual species interaction between P. gingivalis and F. nucleatum 
 F. nucleatum and P. gingivalis work synergistically during growth, as P. gingivalis 
stimulates F. nucleatum biofilm formation (122), and F. nucleatum supports the 
growth of P. gingivalis in aerated and CO2 depleted environment (99). The effect of 
the presence or absence of F. nucleatum on anaerobe survival was tested on both 
planktonic and biofilm lifestyles in a complex community of oral bacteria grown in a 
partially aerated chemostat system. P. gingivalis number was significantly reduced in 
the absence of F. nucleatum and coaggregation-mediated interaction facilitated the 
survival of the obligate anaerobes (98).  
The coaggregation between the two species is mediated by a galactoside moiety on 
the P. gingivalis surface and a lectin on the F. nucleatum and this coaggregation has 
been shown to be inhibited by lactose, galactose and other related sugars (123). F. 
nucleatum significantly enhances the adherence of P. gingivalis to hydroxyapatite 
discs (124) and also to flow-cell glass biofilms (Fig. 5) when they are grown together 
(30). The virulence of P. gingivalis LPS was shown to be enhanced by co-culture with 
F. nucleatum compared to the virulence of LPS from P. gingivalis cultured alone 
(125). 
The dual species model composed of F. nucleatum and P. gingivalis was also used on 
human cell lines in vitro to study the inflammatory effect and the invasion ability of 
the bacteria to the cells (126-129). Studies showed an enhancement in the attachment 
of P. gingivalis to human fibroblast and this was mediated by F. nucleatum (128). The 
invasion of the gingival epithelial cells by P. gingivalis was shown to be enhanced by 
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co-infection of these two species, and this cell entry was modulated by F. nucleatum 
and dependent on lipid rafts (126). Mixed infection also appears to significantly 
provoke the inflammatory response in epithelial cells (KB cells), as higher levels of 
interleukins 6 and 8 were detected when F. nucleatum ATCC25586 and P. gingivalis 
ATCC33277 were co-cultured with KB cells (127). 
The dual species model composed of F. nucleatum and P. gingivalis was also used in 
vivo with mouse models (130-133). Infection of mice with a combination of P. 
gingivalis and F. nucleatum elicited a significantly greater lesion (abscess) size 
(P<0.001) and lethality compared with P. gingivalis alone (132) and synergistic 
pathogenicity was also shown in the mouse subcutaneous chamber model (131).  
 
 
Figure 5. 24 h old dual species biofilm composed of F. nucleatum and P. gingivalis, grown in the flow-
cell biofilm model and stained with Live/dead stain. (Source: Marwan M A Mohammed). 
Experimental periodontitis was induced by F. nucleatum and P. gingivalis in a mouse 
model and the mice showed significantly more bone loss compared with that of 
mono-infected mice (130). Increased levels of inflammatory mediators (TNF-α and 
IL-1β) were also demonstrated, compared with the levels in the mono-infected group 
(130). Vaccinated mice with either bacteria (heat killed whole bacteria) were also 
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challenged in a subcutaneous chamber model and in an experimental periodontitis 
(oral infection) model (134). The mice immunized against either bacteria showed 
decreased TNF-α but not IL-1β, compared to non-immunized mice (134). The level of 
bone loss induced by the infection with dual species showed no change with 
vaccination even though the antibody titers were still high (134). 
Materials and substances with potential antibacterial properties were also tested in the 
dual species model composed of F. nucleatum and P. gingivalis which include 
cranberry polyphenol (135), povidone-iodine (136) and ruthenium based sensitizer 
(137).  When tested with povidone –iodine the dual species biofilm showed an 
approximately 200-fold increase in the viable count compared with mono-microbial 
biofilm (136). This indicates how these two species can support each other during 
stress. 
The extracellular polymeric substances of the dual species biofilm have been explored 
and shown to be rich in proteins, carbohydrates and nucleic acids (30). The matrix 
proteins of the dual species biofilm have been identified, quantified and compared 
with mono-species biofilm matrix. Several proteins were recognized as 
oxidoreductases and chaperons have been shown to be among the most abundant 
proteins (138). 
F. nucleatum and P. gingivalis are also members of the 10-species subgingival Zurich 
biofilm model (139) that is composed of frequently studied plaque bacteria 
representing early, intermediate and late colonizers of the subgingival biofilm (139, 
140).  F. nucleatum and P. gingivalis have also been included in a three species 
biofilm model of oral microbial community where Streptococcus gordonii was the 
third species and represented the early colonizers. This model was used to study the 




1.6 Methods used to study bacterial biofilms 
Numerous approaches have been used to study biofilm formation, but as yet there is 
no single ideal model system (144). Selection of model systems depends on many 
factors including the type and characteristics of the targeted bacteria, the aim of the 
investigation, the preferences of the investigator and other more objective criteria 
(144, 145). 
There are two practical models for studying biofilms, static systems that are more 
suitable to exploring early events in biofilm formation, and continues flow or 
chemostat systems, which are preferable for mature biofilm studies (144, 146, 147). 
One example of each system will be described in this overview. 
 The microtiter plate biofilm assay is a popular static model used to assess bacterial 
attachment by measuring the adherent biomass. Also known as the 96-well plate assay 
and first mentioned by Christensen et al. (148), and the protocol was modified and 
promoted in the 1990s (146, 149, 150). Being user friendly with high-throughput 
capacity makes it among the most frequently used biofilm models, with the advantage 
of low cost as it uses small amount of reagents. The system has good versatility with 
ability to grow biofilm on the bottom of the wells or on a coupon made of different 
materials placed in the well. Another variation is to grow biofilm on pegs attached to 
the plate-lid, as in the system developed by Ceri et al. and then patented and marketed 
as the Calgary Biofilm Device and later as the MBEC Device by Innovotech (151).  
The microtiter plate biofilm model can be used in many applications. It was used in 
testing the ability of the bacterial strains to form biofilm (152), screening for the 
antimicrobial and anti-biofilm effect of different substances (153)  and examining the 
effect of different modifications in the growth environment including coating, growth 
media, temperature, humidity, etc. (154). 
The flow cell biofilm model is an example of growing biofilm in hydrodynamic 
conditions (Figure. 6) (147). This method allows a good microscopic visualization for 
developing biofilm (145). As the biofilm has a three-dimensional structure, confocal 
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laser scanning microscopy (CLSM) with appropriate molecular staining can help to 
obtain a spatiotemporal follow up of biofilm formation (147, 155). 
 
 
Figure 6. Schematic illustration of the flow cell system, medium bottle (a) the pump (b) the bubble trap 
(c) the flow cell (d) and the effluent bottle (e). Adopted from (147) 
 
With CLSM it is possible to view live biofilm samples of fluorescent labeled bacteria 
that have not subjected to any fixation distortion (155). In this model the biofilm is 
grown on glass coverslip sealed with silicone glue to a polycarbonate block with 
channels that have a design compatible with typical microscope slide mounting 
apparatus (147, 155). The block is connected with tubing to the source of the medium, 
pump and bubble traps in one end and to the waste container on the other end. 
Different staining techniques can be used to visualize biofilms and/or the matrix 
(EPS) (155), including  florescent proteins, fluorescent in situ hybridization and 





1.7 Proteome analysis 
The proteome is defined as the entire set of proteins expressed by a genome, cell, 
tissue, or organism at a certain time. The term was first introduced by Marc Wilkins 
(156), combining the two words “protein” and “genome”. Compared to the relatively 
static genome, the proteome is dynamic and complex as protein expression is affected 
by three main potential modification states (glycosylation, phosphorylation and 
ubiquitination), and may be followed by additional modification (e.g. another 
phosphorylation, acetylation, protease cleavage, lipidation, acetylation, etc.). This 
leads to diverse forms of protein expression, called protein isoforms, and post-
translation modifications (157). While genomics and transcriptomics provide basic 
information on DNA sequences, regulatory elements, and gene expression, 
proteomics provides quantitative information on the total protein profile of a cell, 
tissue, or organism at specific time points. It also takes into account the relative 
abundance, distribution, functions and interactions with other macromolecules (158). 
 
1.6.1 Proteomics of oral bacteria associated with periodontal diseases  
Unlike the genome, it is difficult to find the whole proteome expressed by a cell or 
organism due to the complexity of the proteome, as it changes depending on 
abundance, post-translation modification, cell location and interaction with other 
proteins, all of which can change quickly (158).  
The characterization of proteins expressed by oral bacteria under a range of in vitro 
growth conditions was started with one species at a time, usually under planktonic 
growth condition (159), followed later by proteomic analysis for bacteria grown in a 
biofilm and most recently in multi-species biofilm models (160). 
One of the targeted bacteria for proteomic analysis is P. gingivalis, due to its strong 
association with periodontal diseases and the fact that it is the easiest red complex 
member to grow and manipulate (71).  Differential protein expression by P. gingivalis 
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in response to secreted epithelial cell components was studied by Zhang et al. and 
1014 proteins (46% of the total theoretical proteome) were identified in four 
independent analyses (161). Among the proteins up-regulated in the presence of 
epithelial cell components was a homolog of the internalin proteins of Listeria 
monocytogenes and subunits of the ATP-dependent Clp protease complex (161). 
Proteomic analysis of P. gingivalis grown in an oral microbial community with F. 
nucleatum and Streptococcus gordonii showed a decrease in proteins involved in cell 
shape and the formation of the cell envelope, as well as thiamine, cobalamin, and 
pyrimidine synthesis and DNA repair (141). An overall increase was seen in proteins 
involved in protein synthesis and HmuR, a TonB dependent outer membrane receptor, 
was up-regulated in the community (141). In a polymicrobial biofilm composed of the  
anaerobic proteolytic species P. gingivalis, T. denticola and T. forsythia which are 
said to be strongly associated with chronic periodontitis (65), proteomic analysis 
showed a change of plan in iron acquisition by P. gingivalis due to large increases in 
the abundance of HusA and HusB in the polymicrobial biofilm, while HmuY and 
other iron/haem transport systems decreased (162). Significant changes in the 
abundance of peptidases and enzymes involved in glutamate and glycine catabolism 
suggest syntrophy (162). In a study of the outer membrane vesicles of P. gingivalis, it 
has been shown that they contain outer membrane and periplasmic proteins and carry 
a cargo enriched with virulence factors (85). Two recent studies of the extracellular 
proteome of P. gingivalis have now identified the most abundant proteins, major 
virulence related proteins, outer membrane proteins (138, 163) and citrullinated 
extracellular proteins (163). 
A. actinomycetemcomitans is another putative periodontal pathogen that has received 
significant attention due to its strong association with severe periodontitis in younger 
individuals (164). The cell envelope proteome of A. actinomycetemcomitans shows a 
broad range of different proteins, including surface adhesins, porins, lipoproteins, 
numerous influx and efflux pumps, multiple sugar, amino acid and iron transporters, 
and components of the type I, II and V secretion systems (165). In another study, the 
secretome of A. actinomycetemcomitans has been shown to contain putative virulence 
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determinants including DegQ, fHbp, LppC, Macrophage Infectivity Protein (MIP), 
NlpB, Pcp, PotD, TolB, and TolC (166). The interactions between A. 
actinomycetemcomitans and other bacterial species in an in vitro 10-species 
"subgingival" biofilm model have been studied using proteomic analysis (167), and 
there were shown to be distinct protein regulation patterns, with the regulated groups 
of proteins being primarily responsible for changes in the metabolic rate, the ferric 
iron-binding, and the 5S RNA binding capacities, at the universal biofilm level (167). 
While the presence of A. actinomycetemcomitans did not disturb the numeric 
composition or absolute protein numbers of the other biofilm species, it triggered 
qualitative changes in their overall protein expression profile (167). 
F. nucleatum, a bacterial species known for its capacity to coaggregate with other 
species within the oral biofilm, acting as a bridge between early and late colonizers, 
has also been subjected to multiple proteomic studies (96, 143, 168-170).  Zilm et al. 
have explored how the proteomic profile of F. nucleatum is regulated by growth pH. 
Differentially expressed proteins associated with increased energy (ATP) production 
via the 2-oxoglutarate and Embden-Meyerhof pathways appeared to be directed 
towards either cellular biosynthesis or the maintenance of internal homeostasis (168). 
The ampicillin resistant F. nucleatum showed up-regulated expression of these 
proteins, a class D beta-lactamase, ATP-binding cassette (ABC) transporter ATP-
binding protein and enolase (169). In response to oxidative stress, three major protein 
systems of F. nucleatum were altered. Proteins of the alkyl hydroperoxide 
reductase/thioredoxin reductase system were increased in intracellular concentration, 
glycolytic enzymes were modified by oxidation and the intracellular concentrations of 
molecular chaperone proteins and related proteins (i.e. ClpB, DnaK, HtpG, and HrcA) 
were increased (96). In alkaline-induced F. nucleatum biofilms, the intracellular 
concentration of stress response proteins including heat shock protein GroEL and 
recombinational protein RecA increased markedly in an alkaline environment (170). 
There was increased abundance of an adhesin, Fusobacterial outer membrane protein 
A (FomA), known for its capacity to bind to a vast number of bacterial species and 
human epithelial cells and its increased abundance has been associated with biofilm 
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formation (138, 170). The proteomics of F. nucleatum in a microbial community 
model with S. gordonii and P. gingivalis showed extensive changes in energy 
metabolism, and all multispecies comparisons showed reductions in amino acid 
fermentation and a shift toward butanoate as a metabolic byproduct (141), with 
functional analysis showing reduced translation, lipopolysaccharide, and cell wall 
biosynthesis, DNA replication and DNA repair in the community (141).  
A proteomic overview of regulated pathways of host-biofilm interaction models, 
provides insights into the early events of periodontal pathogenesis (171). An in vitro 
periodontal organotypic tissue model in a perfusion bioreactor system was used in 
co-culture with an 11-species subgingival biofilm, and F. nucleatum, P. gingivalis 
and A. actinomycetemcomitans were among the species grown in that biofilm (171). 
Most secreted bacterial biofilm proteins derived from their cytoplasmic domain and in 
the presence of the tissue, the levels of F. nucleatum, Actinomyces oris and 
Campylobacter rectus proteins were significantly regulated, and the functions of the 
upregulated intracellular (biofilm lysate) proteins were associated with cytokinesis 
(171). 
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2. Aim of the study 
The main aim of the project was to study in depth and characterize a dual species 
biofilm composed of F. nucleatum and P. gingivalis in vitro using molecular imaging 
techniques and proteomics. Furthermore, we explored the extracellular polymeric 
substances in the biofilm matrix of the dual and mono-species biofilm, followed by 
protein identification and analysis of their differential expression.  
 
The specific aims: 
- To establish and maintain an in vitro model for dual species biofilm composed 
of Fusobacterium nucleatum and Porphyromonas gingivalis. 
- To characterize extracellular polymeric substances in the biofilm matrix and to 
analyze enzymatic effects on early and mature biofilms formed by F. 
nucleatum and P. gingivalis.  
- To identify and quantify proteins in the EPM of F. nucleatum and P. gingivalis 
when grown in mono- or dual-species biofilms. 
- To study the functional characterization of the protein profiles of F. nucleatum 
and P. gingivalis when grown as mono- or dual-species biofilms or under 




3. Materials and Methods (mainly derived from Paper I - III) 
3.1 Paper I 
 
Bacteria and growth medium 
Fusobacterium nucleatum subsp. nucleatum, type strain ATCC 25586 and 
Porphyromonas gingivalis type strains ATCC53978 (W50), ATCC 33277 and ATCC 
BAA-1703 (FDC 381) were used in this study. 
The bacterial strains were grown on fastidious anaerobic agar (FAA) plates at  37°C 
in anaerobic condition (5% CO2, 10% H2, and 85% N2) (Anoxomat System) for 48h 
and then inoculated in liquid medium prepared with the  following : tryptone (Oxoid 
Ltd., London) (15 g/L); NaCl, (5 g/L); KH2PO4, 1.5 g/L); Na2HPO4.2H2O, (3.5 g/L) 
;NaHCO3, (0.5 g/L) and yeast extract (Oxoid), (3.0 g/L). Filter sterilized ascorbic acid 
(1 mg/L), vitamin B12 (0.1 mg/L), glucose (5.5 g/L) and hemin (5 mg/L) were added 
to the autoclaved part of the medium (172). The bacteria were incubated for 24h at 
37°C in anaerobic condition and used as the source of culture inoculum in the 
dynamic and static biofilm models. 
The flow cell biofilm  
Biofilms were grown at 37°C in three-channel flow cells with individual channel 
dimensions of 1 x 4 x 40 mm. The flow system was assembled and prepared as 
described by Christensen et al (173). A glass cover slip (24 x 50 mm) was used as 
substratum for biofilm growth. Before each experiment, the flow cell system was 
autoclaved, and after assembling, the system was sterilized by pumping a 0.5% 
(wt/vol) hypochlorite solution into the system and leaving it there for 4 h. The system 
was flushed with 2L of sterile water after which the flow chamber was filled with 
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media and allowed to sit overnight at 37°C to let the system equilibrate with the 
medium. Inocula were prepared as follows: bacteria grown for 48h on FAA plates 
were re-suspended in liquid media and incubated overnight at 37°C. After adjusting 
the optical density at 550nm to 0.5, aliquots of 250 µl cultures were injected into each 
channel of the flow cell after stopping the medium flow and clamping off the silicon 
tubing to prevent back flow into the system. The flow cell was inverted for one hour 
to allow for adhesion of cells to the glass surface without flow. Then the flow was 
resumed and the clamps removed. During growth of biofilms the fresh medium was 
pumped through the flow cells at a constant rate of 3.3 ml/h/channel by using a 
peristaltic pump (Watson-Marlow, Falmouth, UK) (174). 
The biofilm for EPS extraction   
Petri dishes with a diameter of 9 cm (Nunc, Rochester, NY, USA)  containing 20 ml 
of liquid medium each were inoculated with 100 µl of bacterial suspension 
(OD550nm=1). The dishes were incubated in anaerobic conditions (without shaking) at 
37°C for 5 days. Then the medium was removed and the biofilm samples washed 
twice with phosphate buffered saline (PBS) before the biofilms were harvested by 
scraping with cell scraper (Nunc, Rochester, NY, USA). The biofilm samples were 
suspended in 1ml PBS and stored at -20°C until processing. 
Enzymatic treatment of harvested biofilm 
The biofilm samples were homogenized with FastPrep FP120 Thermo Savant 
homogenizer (Qbiogene, Cedex, France) at a speed of 4 m/sec for 20 seconds, then 
Proteinase K (Sigma-Aldrich, MO, USA) was added  to 500 µl of each sample to 
yield a final concentration of 5 µg/ml as described (18, 29). Samples with added 
distilled water were used as controls. Enzyme treated samples and controls were 
incubated at 37°C for 1h. After enzymatic treatment, the biofilm samples and controls 
were filtered through 0.2 µm pore size acrodisc syringe filters (Pall, BioSciences, Ann 
Arbor, MI, USA). Aliquots from the eluate were used for quantification of proteins 
and carbohydrates and extraction of DNA. 
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Protein concentration assay 
For the measurement of the protein concentration the samples and controls were 
diluted 10 times in distilled water and then 0.5 ml of Lowry reagent was added to 0.5 
ml of this sample. After 20 min at room temperature, 0.5 ml of Folin and Ciocalteu’s 
phenol reagent working solution (Sigma-Aldrich, MO, USA) was added to the 
mixture and left for another 30 min at room temperature (25). The absorbance of the 
standards and samples were measured at 750 nm and compared to a standard curve 
obtained by serial dilution of bovine serum albumin. 
Carbohydrate assay 
The carbohydrate concentration in EPM was measured by the anthrone method with 
the modifications described by Raunkjær et al (18, 175), using glucose as a reference 
standard. The samples and controls were prepared by 10 times dilution in distilled 
water, and then 100 µl of each diluted sample was mixed with 200 µl of anthrone 
reagent (0.125% anthrone [wt/vol] in 94.5% [vol/vol] H2SO4). Samples and controls 
were placed in a water bath at 100°C for 14 min and then cooled at 4°C for 5 min. 
The absorbance at 595 nm was measured using microtitre plate reader (Multiskan MS 
Type 352, Labsystems, Finland).  
 eDNA extraction and quantification 
Extraction of eDNA was performed by using Fast DNA spin kit (MP Biomedicals, 
Solon, Ohio, USA) according to the manufacturer’s instructions. Measurements of 
DNA concentration in 500 µl from each sample were done by NanoDrop 
spectrophotometer (Thermo Fisher Scientific Inc. Waltham, MA, USA). 
The eDNA was electrophoresed on a 0.8% agarose gel from SeaKem (FMC 
BioProducts, Rockland, ME, USA) and stained with GelRed™ (Biotium, Hayward, 
CA, USA) using 0.5x TBE buffer at 100V for 40 minutes. EZ load 100-bp molecular 
ruler (Bio-Rad, CA, USA) was used as DNA standard. 
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Static biofilm microtitre plate assay  
Black 96 well clear flat bottom polystyrene untreated microplates (cat. no. 3631, 
Corning, NY, USA) were used to grow biofilms. The effect of the enzymes was 
evaluated on biofilm formation and mature biofilm (29). Deoxyribonuclease I (DNase 
I) (Sigma-Aldrich, MO, USA) from bovine pancreas was prepared in enzyme buffer 
(0.15 mM NaCl and 5mM MgCl2) and proteinase K was prepared in distilled water. 
The two enzymes were used in different concentrations (0.125, 0.25, 0.5, and 1 
mg/ml). The enzyme buffer (for DNase I) and distilled water (for proteinase K) were 
used for the controls. The bacteria were prepared by diluting overnight grown 
bacterial cultures to prepare suspensions of 1.2x107 cfu/ml. 
 A total of 200 µl from the bacterial suspension was used in each well of the 
microplate to grow biofilm, for dual species biofilm equal amounts (100 µl) from 
each bacteria were used. 
To evaluate the effect of DNase I and proteinase K on biofilm formation the enzymes 
were added and then the microplates were incubated in anaerobic conditions at 37° C 
for 48h. To evaluate the effects on mature biofilm a 48 h old biofilm was washed with 
PBS, and then the enzymes were added in their respective buffers and incubated for 
1h at 37° C. 
The medium and enzymes were removed and the wells were washed once with 
distilled water. The biofilm was then stained with 150 µl of crystal violet (0.5 %) for 
15 min, the stain was removed and the biofilm was washed twice with distilled water 
and left to dry. To solubilize the stain 150 µl of 95% ethanol was added to each well, 
the absorbance was read at 570 nm in an automatic ELISA microplate reader 
(Multiskan MS Type 352, Labsystems, Finland). 
CLSM was used to visualize the effect of enzymes on biofilm formation and on 
mature biofilm. In brief, the biofilm was grown in µ-clear bottom, chimney well, 
surface treated, sterile 96 wells microtitre plates (cat. no. 635090,Greiner Bio-One, 
Frickenhausen, Germany) in the same conditions as described above. The 
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concentrations of DNase I and proteinase K used on the biofilm examined by CLSM 
were 1mg/ml.  
CLSM of biofilms in flow cells and microtitre plates 
The biofilms were examined using a Zeiss LSM 510 META equipped with a water-
immersion 63x objective (Carl Zeiss, Jena, Germany). The biofilms were stained for 
15 min with 100 µl LIVE/DEAD BacLight Bacterial Viability Kit (Invitrogen 
Corporation, NY, USA), The final concentrations of Syto-9 and propidium iodide (PI) 
were 0.01 mM and 0.06 mM, respectively. The SYPRO® Ruby biofilm matrix stain 
(Invitrogen Corporation, NY, USA) was used to stain proteins in the EPM. The green 
fluorescence and red fluorescence of SYTO 9 and PI were excited using an argon 
laser beam with excitation lines at 488 nm and a helium/neon at 543nm, respectively. 
The SYPRO® Ruby stain was excited at 405nm with diode laser. The CLSM image 
stacks were analysed by the image-processing software COMSTAT (176). The 
biomass, average thickness and maximum thickness were the parameters used to 
compare different biofilms.  
Statistical analyses 
The IBM SPSS 19.0 software package was used for the statistical analyses. The 
means and standard deviations of carbohydrates and eDNA concentrations in 
harvested biofilms treated with proteinase K were calculated and Mann–Whitney U-
test was used to compare the means. The means and standard deviation of absorbance 
values representing the effect of DNase I and proteinase K on early biofilm formation 
or mature biofilm were calculated for each enzyme concentration and each tested 
biofilm. Multiple comparisons within groups were performed by Kruskal-Wallis test 
and if significant Mann–Whitney U-test as post hoc testing is used. The significance 
level was set to p < 0.05. 
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3.2 Paper II & III 
Bacteria and growth medium 
Fusobacterium nucleatum subsp. nucleatum type strain ATCC 25586 and Porphyromonas 
gingivalis type strain ATCC 33277 were used in the current study. The bacterial strains were 
grown on fastidious anaerobic agar (FAA) plates at 37°C in anaerobic conditions (5% CO2, 
10% H2, and 85% N2) (Anoxomat System, MART Microbiology, Lichtenvoorde, 
Netherlands) for 48h. A few colonies of each species were then used to inoculate Brucella 
broths (Becton Dickinson, Sparks, MD, USA) supplemented with 5 µg/ml hemin and 0.25 
µg/ml vitamin K. The bacteria were grown overnight in the liquid medium under 37°C under 
anaerobic conditions.  The overnight cultures were adjusted to an absorbance of 0.15 at 600 
nm (A600), whereof 10 ml was transferred to a separate 25 cm2 (area) polystyrene cell culture 
flask (cat.no 90026, TPP, Trasadingen, Switzerland) to prepare mono species biofilms, and 5 
ml from each species was transferred to prepare dual species biofilm. We cultured the 
biofilms in an in vitro static biofilm model (177), the flasks were incubated at 37°C under 
anaerobic conditions for 4 days without any additional supply of fresh medium. After 
medium removal, the biofilm samples were washed once with phosphate buffered saline 
(PBS) to remove free-floating bacteria and the attached biofilm was harvested with a cell 
scraper (Nunc, Rochester, NY, USA). The collected biofilms were then re-suspended in 500 
µl PBS and stored at -20°C until further processing. The planktonic cultures were grown 
with same medium in 10 ml glass tubes for 4 days, and the bacteria collected by 
centrifugation. 
 
Biofilm Viability by Colony forming unit (CFU) counting 
The viability of the bacterial cells was determined by counting CFU of the initial inoculum 
and of the mature 4 days-old biofilm. Three independent biological replicates were serially 
diluted, selected dilutions plated on FAA medium, and incubated anaerobically at 37°C for 4 
days. The colonies formed on the plates were counted and used for calculating estimated 




Figure 7. The experimental workflow included the harvesting of biofilm samples, processing of cell extracts, 




Extraction of EPM 
The biofilm samples were mechanically sheared with FastPrep FP120 Thermo Savant 
homogenizer (Qbiogene, Cedex, France) at a speed of 4 m/sec for 20 seconds, in Eppendorf 
tubes, without any cell-disrupting beads, to avoid contamination from cellular proteins. The 
samples were then filtered through 0.2 µm pore size acrodisc syringe filters (Pall, 
BioSciences, Ann Arbor, MI, USA) to remove  cells and cellular debris (18). Aliquots from 
each eluate were used in further work. Direct Detect® Spectrometer (Merck Millipore, 
Darmstadt, Germany) was used for protein concentration measurements. Low concentration 
samples of P. gingivalis EPM were concentrated by using Amicon Ultra-0.5 centrifugal filter 
devices with 3K Da cutoffs (Merck Millipore, Darmstadt, Germany). 
Sample preparation for the proteomic analysis  
In order to generate a statistically robust proteomic dataset, samples with EPM extracts of 
mono- and dual-species biofilms from different culture flasks were prepared in four 
biological replicates (Paper II) or three biological replicates (Paper III). Filter Aided Sample 
Preparation (FASP) method developed by Wisniewski and co-workers (178), was used with 
minor modifications for the samples processing. Briefly, EPM samples were mixed in a 
solution of 10 mM dithiothreitol (DTT) in 100 mM ammonium bicarbonate (NH4HCO3) 
[solution to total protein ratio (v/w) 1:10] and incubated for 45 min at 56°C. Microcon 
device YM-10 filters (Merck Millipore, Darmstadt, Germany) were first conditioned by 
adding 100 µl of urea buffer (8M urea, 10mM HEPES, pH 8.0) and centrifuged at 14,000xg 
for 5 min. This and the following steps were carried out at room temperature, unless 
otherwise stated. Aliquots of EPM samples containing 50 µg of protein were mixed with 200 
µl urea buffer in the filter unit and centrifuged at 14,000xg for 15 min and this step was 
repeated one more time. The filtrate was discarded and 100 µl of 0.05 M iodoacetamide was 
added to each sample. The samples were mixed at 600 rpm for 1 min in a thermo-mixer and 
incubated without mixing in the dark for 20 min, followed by centrifugation at 14,000xg for 
10 min, three washes with 100 µl urea buffer and another three washes with 100 µl 40 mM 
NH4HCO3 in H2O. EPM remaining on the filter were digested with trypsin (Thermo Fisher 
Scientific, IL, USA) in 40 mM NH4HCO3 buffer [enzyme to protein ratio 1:50 (w/w) ] at 
37°C for 16 h. The released peptides were collected by adding 50 µl of mass spectrometry 
grade water followed by centrifugation at 14,000xg for 15 min. This step was repeated twice. 
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Samples were concentrated (to 20-40 µl volume) in a vacuum concentrator (Eppendorf, 
Hamburg, Germany). 
Filtration and desalting 
 StageTips for filtration and desalting were prepared by packing 3M Empore C18 extraction 
disks (3M, MN, USA) in 200 µl pipet tips by a blunt ended needle and a plunger or metal rod 
that helped to fit the extracted disks in the pipet tips, according to the protocol developed by 
Rappsilber and colleagues (179). The disks were wetted by passing 20 µl of methanol, 
followed by 20 µl of elution buffer [80% acetonitrile (ACN), 0.1% formic acid (FA)]. The 
disks were then conditioned and equilibrated with 20 µl of 0.1% FA just before the last 
residue of the previous buffer left the tip to avoid drying of the disks. Samples (volumes 20-
40 µl) were loaded on top of the StageTip.  The disks with samples were desalted by washing 
with 20 µl of 0.1% FA and were transferred to new tubes. Peptides were eluted and collected 
by adding 20 µl elution buffer twice. The collected samples were dried in a vacuum 
concentrator and stored at -80°C for further analysis. Peptide samples were resuspended by 
adding 1 µl of 100% FA and 19 µl of 2% ACN prior to liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) analysis.  
Data analysis 
The acquired MS raw data were processed using the MaxQuant software (180), version 
1.5.2.8, with default settings. Label-Free Quantification (LFQ) (181) and match between 
runs, which is based on retention time alignment between different replicates, were optional 
software features, which were used in the MS/MS data searches. The MS spectra were 
searched against protein databases of either F. nucleatum type strain ATCC 25586 or P. 
gingivalis type strain ATCC 33277. The respective files were downloaded from the UniProt 
knowledgebase on the 4th of February 2015. The mass spectrometry proteomics data have 
been deposited to the ProteomeXchange Consortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE (182) partner repository with 
the dataset identifiers PXD004888 (Paper II) and PXD008288 (Paper III).  
Post MaxQuant analysis included filtering of the generated ‘proteingroups.txt’ table for 
contaminants, only identified by site and reverse hits by the Perseus software (183). Each 
protein identified in at least two out of four replicates was considered valid. To discriminate 
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differential expressions of proteins present both in the mono- and dual-species biofilm, t-test 
with p-value ≤ 0.05 was used. 
Functional protein annotation was performed using the Database for Annotation, 
Visualization and Integrated Discovery (DAVID) (184). Predictions of the identified proteins 
subcellular localization were performed by web-based application SOSUI-GramN (185). 
VirulentPred (186) was employed to predict the virulence factors among identified bacterial 
proteins, and the predictions were derived from the Cascased SVM (Support Vector 
Machine) module (187). The protein lists were also searched for beta-barrels integral outer 




4. Summary of the results 
4.1 Paper I 
Proteins and carbohydrates were the major components of the biofilm matrix, and 
extracellular (eDNA) was also present. The average concentration of  proteins among 
the tested samples was 666 µg/ml, for carbohydrates it was an average of 682 µg/ml, 
for eDNA an average of 25 µg/ml. The matrix component showed variation among 
the species, with proteins and carbohydrates highest in EPM extracted from F. 
nucleatum and P. gingivalis W50 biofilms and lowest in F. nucleatum and P. 
gingivalis FDC381 biofilm. Proteinase K treatment had no effect on the concentration 
of the yielded eDNA or carbohydrate from the treated matrices. 
DNase I and proteinase K treatments had no significant effect on biofilm formation or 
on mature biofilms under the conditions used.  
In the flow-cell biofilm model, F. nucleatum was able to grow under partially 
oxygenated conditions while P. gingivalis failed to form biofilm alone in similar 
conditions but it can grow with F. nucleatum as dual species biofilm. 
4.2 Paper II 
We identified 542, 93 and 280 proteins from the matrix of F. nucleatum, P. 
gingivalis, and the dual-species biofilm, respectively. Nearly 70% of all EPM proteins 
in the dual-species biofilm originated from F. nucleatum, and a majority of these were 
cytoplasmic proteins, suggesting an enhanced lysis of F. nucleatum cells. The 
proteomic analysis also indicated an interaction between the two species: 22 F. 
nucleatum proteins showed differential levels between the mono and dual-species 
EPMs, and 11 proteins (8 and 3 from F. nucleatum and P. gingivalis, respectively) 
were exclusively detected in the dual-species EPM. Oxidoreductases and chaperones 
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were among the most abundant proteins identified in all three EPMs. The biofilm 
matrices also contained several known and hypothetical virulence proteins, which can 
mediate adhesion to the host cells and disintegration of the periodontal tissues. 
4.3 Paper III 
Comparisons between the protein profiles for the two bacterial species showed 
significant changes under all the conditions tested, i.e. when they were grown in 
biofilm or planktonic conditions, and when they were grown in mono- or in dual-
species biofilm settings. In the F. nucleatum biofilm 5 proteins showed changes from 
the planktonic condition, including increased proteins involved in vitamin B 
metabolic processes. In the P. gingivalis biofilm 40 proteins were changed: 30 
increased and 10 decreased. Among the increased proteins, putative cell division 
trigger factor and riboflavin biosynthesis proteins were the most increased in this 
biofilm. To describe interactions between the two species at the protein level, we 
grew the bacteria both individually and together. In the mixed species biofilm culture, 
112 proteins showed significant changes, including 72 proteins derived from F. 
nucleatum and 40 proteins from P. gingivalis. By comparing dual-species to mono-
species in biofilm and under planktonic growth conditions, P. gingivalis showed more 
proteins with a decreased level in the dual-species conditions.  
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5. Discussion  
5.1 Methodological considerations 
The present study was done in vitro using different laboratory methods, material and 
equipment. Growing anaerobic bacteria in a biofilm model is technically challenging 
because it needs to be practically valid, reproducible and representative.  
Paper I 
A flow cell biofilm model was used to grow the biofilms. The main advantage of this 
model is the flow conditions can be controlled. This model in combination with 
confocal microscopy is perfect for the organisms that can be fluorescently tagged, and 
it gives a good spatiotemporal overview of the bacterial biofilm (155). In a flow cell 
model P. gingivalis was not able to form biofilm in partially oxygenated condition but 
biofilm is easily formed under strict anaerobic conditions (189). In our study, we 
showed that F. nucleatum was able to grow in partially oxygenated conditions and it 
can support the growth of P. gingivalis in the dual species biofilm (30). A limitation 
of this model is that our bacteria were not fluorescently tagged and we used live/dead 
stain to view the biofilm, thus we were unable to do time point analysis for the same 
biofilm. In addition, it was difficult to harvest enough biofilm to do further analysis of 
the samples, and contamination with aerobic bacteria was highly prevalent. We 
therefore changed to other models that allowed us to harvest mature biofilm with 
dense EPS matrix for further analyses. 
 
To visualize the effect of enzymatic treatment on biofilm shape and structure, we used 
µ-clear 96 well plates, which have a thin glass bottom that allows visualization under 
confocal microscopy. Although there was some small effect of DNase enzyme on the 
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shape of the biofilm under confocal microscopy (Figure 8) this did not affect the main 
structure of the biofilm. 
  
Figure 8: Confocal images of F.nucleatum 25586 and P.gingivalis 33277  in 48h old biofilms. (a) 
without enzyme treatment (b) treated with 1mg/ml DNase I (c) treated with 1 mg/ml proteinase K. 
 
Paper II 
In order to understand basic principles of biofilm organization at a molecular level, 
identification of ECM components is essential. Most extraction methods for 
extracellular polymeric substances (EPS) were adapted from the marine or 
environmental microbiology fields. The extraction methods can be classified as either 
physical or chemical (190). Unfortunately, there is no universal standard EPS 
isolation method, and the extraction procedure has to be modified to the specific type 
of biofilm under investigation (12). In our study, we elected to physically shear the 
biofilm using a homogenizer without disrupting beads in order to avoid contamination 
from cellular proteins. We also avoided the use of any chemicals in the extraction 
procedure because the presence of certain chemicals in EPS extracts results in severe 
underestimation of proteins from the samples (190). Physical shearing was followed 
by filtration to remove cells and any cellular debris. 
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Paper II and III 
Mass spectrometry has emerged as a core tool for large-scale protein analysis. In the 
past decade there has been rapid improvement in the resolution, mass accuracy, 
sensitivity and scan rate of mass spectrometers used to analyze proteins. In addition, 
hybrid mass analyzers have been introduced recently (e.g. Linear Ion Trap-Orbitrap) 
which have significantly improved proteomic analysis (191). Shotgun proteomics 
provides an indirect measurement of proteins through peptides derived from 
proteolytic digestion of intact proteins and is considered as a “bottom-up” protein 
analysis (191). Relative quantification of proteins, especially label-free quantification 
in high throughput shotgun proteomics, have also developed rapidly in recent years. It 
can help to avoid additional sample processing steps, cost of labeling reagents, 
inefficient labeling, difficulty in analysis of low abundance peptides, and limitation of 
sample number which are all drawbacks associated with the use of labeling 
techniques. With the advent of a large number of fast, accurate, and sensitive 
instruments and software programs for validation, label free quantification is 
becoming a common substitute for the use of labeling methods (191). 
5.2 Discussion of the main findings 
There is a shortage of studies on EPM of oral subgingival biofilms. However, exo-
polysaccharides in the supragingival biofilm have been widely studied and identified 
for a long time (192-194).  In the present study, we have isolated EPM and tested the 
effects of DNase I and proteinase K on biofilms of anaerobic periodontal disease 
associated bacteria grown in vitro (Paper I). Furthermore, we used high-resolution 
proteomics to identify and quantify proteins in the EPM of F. nucleatum and P. 
gingivalis grown in both mono- and dual-species biofilms (Paper II).  Finally, we 
compared the proteome profiles of F. nucleatum and P. gingivalis grown in biofilm or 
planktonic mono- and dual-species growth conditions. 
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Extracellular polymeric matrix  
The EPM of the bacterial biofilms is characterized by the presence of macromolecular 
complexes of carbohydrates, proteins and nucleic acids. The enzymatic treatment of 
the harvested biofilms with proteinase K was performed to discover if it would 
increase the liberation of eDNA or carbohydrates compared with simple vortexing or 
homogenizing. This treatment did not result in a significant difference in the yield of 
eDNA or carbohydrates. Wu and Xi found similar results for carbohydrates in 
Acinetobacter sp. strain AC811 biofilm matrix, but the eDNA yield was increased 
after enzyme treatment (18). 
Although proteins were abundant in the biofilm matrix of our F. nucleatum and P. 
gingivalis dual species biofilms, treatment with proteinase K was shown to be 
insufficient to disperse the biofilm matrix. The high carbohydrate concentration in the 
matrix might be responsible for this ineffectiveness, which has also been proposed for 
staphylococcal biofilms (195, 196). The eDNA detected in the EPM in our biofilms 
had a size around 100 bp as demonstrated by agarose gel electrophoresis. This is 
higher than described for other biofilms, however, the size of the eDNA has been 
reported to range from less than 100 bp to 10 kb (197). Treating the eDNA with 
DNase I in the mono or dual species biofilm matrix had no significant effects with 
respect to preventing biofilm formation or dispersing mature biofilms. This is in 
contrast to enzymatic treatment of P. aeruginosa biofilms (22). One suggested 
function of eDNA is gene transfer (198, 199). The biofilm may offer an environment 
conducive to DNA exchange as the cells are in close juxtaposition and DNA can be 
trapped within the extracellular matrix (46). Genus Fusobacterium and other genera 
of oral bacteria contain conjugative transposons that facilitate DNA transfer between 
bacteria through conjugation.  P. gingivalis also shows a large degree of variation 
between strains, suggesting that this organism has gone through frequent genetic 
rearrangements (46, 200).  
An improved understanding of the EPM of subgingival biofilm and complex 
multispecies biofilms in general should lead to more effective control strategies. The 
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management of biofilm growth does not require direct killing of the bacteria in the 
biofilm, but might be directed to degradation or dispersal of the biofilm matrix to 
reverse the biofilm mode of growth to a planktonic state which is significantly easier 
to treat and manage, for example by using antibiotics.   
Flow-cell model 
We have shown that F. nucleatum can grow in a flow-cell biofilm model in a non-
strictly anaerobic environment, while this was not true for P. gingivalis.  There 
appears to be a synergistic enhancement in biofilm formation when these two species 
are grown together, even in a partially oxygenated condition suggesting that F. 
nucleatum might have the capacity to protect P. gingivalis from oxidative stress. This 
has also been reported in other studies (98, 99).  Nearby in vivo association between 
these two microorganisms might indicate that they support each other, as has been 
shown in biofilm and mouse models (122, 131). F. nucleatum and P. gingivalis have 
been found to co-aggregate in vitro and in vivo, which may play a role in biofilm 
formation and pathogenesis as reported in mouse model experiments (130). 
Proteins of the biofilm matrix 
F. nucleatum and P. gingivalis are found in the normal flora of the mouth, they have 
documented roles in the periodontal disease, and their genomes have been sequenced 
(76, 201). The bacteria were cultured for four days which gave a mature biofilm with 
adequate amount of the EPM (30), and also had a minimal effect on the number of 
viable cells in the biofilms. To identify EPM-associated proteins of F. nucleatum and 
P. gingivalis biofilms, the bacteria were grown in cell culture flasks on a plastic 
surface both individually and together, an approach that allowed for investigation of 
possible interactions between the two species at the protein level.  
The number of identified proteins was similar to previous studies on EPMs of 
bacterial biofilms, which reported between 150 and 270 EPM proteins (202, 203). 
Reasons for the high number of protein identifications in the EPM of F. nucleatum 
(542 proteins), when compared to the numbers derived from P. gingivalis and dual-
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species EPMs (93 and 280 proteins, respectively), are not entirely clear. The high 
number of F. nucleatum proteins in the biofilm matrix could be caused by more 
intensive cell lysis, when compared to P. gingivalis. However, only moderate changes 
in the number of viable cells were observed in the growth period of four days. A 
possible mechanism behind cell lysis might be programmed cell death (PCD). F. 
nucleatum has Cid/Lrg homologues of so-called holins, small membrane proteins 
responsible for PCD in the bacteria, whose role is mainly associated with 
permeabilisation of the cytoplasmic membrane and with concomitant protein export 
(204, 205). For example, in S. aureus CidA contributes to biofilm adherence both in 
vitro and in vivo by affecting cell lysis and the release of genomic DNA (206, 207). 
The murein hydrolase exporter (FN0467) and murein hydrolase export regulator 
(FN1531), which are the holins of F. nucleatum, are both found in the proteome of F. 
nucleatum when grown in biofilm or under planktonic conditions (205). Moreover, a 
high number of nucleotide-binding proteins in the EPMs of F. nucleatum and the dual 
species biofilms agree with our previous results showing DNA as a major component 
in the biofilm matrix (30), and further support the occurrence of cell lysis during 
biofilm formation.  
P. gingivalis is an asaccharolytic microorganism (i.e. unable to metabolize 
carbohydrates) while F. nucleatum is able to utilize amino acids, peptides and sugars 
(208). Accordingly, we noticed that most of the detected metabolic pathways in P. 
gingivalis EPM had a role in amino acid metabolism (143). This finding and a 
generally high percentage of other metabolic enzymes detected in the EPMs of both 
F. nucleatum and the dual species biofilms are supportive of the role of the matrix as 
an external source of nutrition and energy production as previously suggested in other 
bacterial biofilms (12, 209). 
Studies on these two organisms found evidence of physiological support 
between the species (99, 131). F. nucleatum is a moderate anaerobe, however, its 
ability to adapt to and reduce an oxygenated environment is extremely high (99). On 
the other hand, P. gingivalis cannot survive in an aerated environment above 6% O2 
when grown as a monoculture, but when grown as a co-culture with F. nucleatum, P. 
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gingivalis can survive O2 levels of up to 20% (99). Proteins associated with oxidative 
stress were abundant in the matrix of the studied biofilms, similar to findings 
described in a study of the P. aeruginosa EPM (202). Oxidative stress response 
proteins were also previously shown to be up-regulated in the biofilms of T. forsythia 
(210) and Campylobacter jejuni (211), when compared to planktonic growth. It has 
been suggested that mixed species biofilms enhance the production of oxidative stress 
proteins because the more strict anaerobes are dependent on oxygen tolerant bacteria 
(212). 
The two-species biofilm model used in this study represents a limited model 
since periodontal diseases develop in a polymicrobial environment. Although biofilm 
models with multiple bacterial species could represent in vivo condition more closely 
(213), such models are difficult to control and manipulate. Biofilm models with only 
two bacteria, such as the F. nucleatum - P. gingivalis model, are more straightforward 
for interpreting possible interactions between the two species. The proteomic analysis 
showed differential production of 22 F. nucleatum proteins between the mono and 
dual-species EPMs and 11 proteins were detected only in the dual-species EPM. 
These results indicate that the two species specifically influence each other at the 
protein level, further supporting synergistic action between these two oral pathogens 
(99, 131). 
Among the most abundant proteins identified in the EPM were molecular 
chaperons. Previously, typical cytosolic proteins GroEL and DnaK were described as 
being associated with membranes and extracellular fractions of F. nucleatum (214). 
Targeting GroEL could represent an antimicrobial strategy with broad-spectrum 
application, and recently a high-throughput screening effort to discover chemically 
and structurally diverse inhibitors of GroEL/GroES has been undertaken (215). 
Moreover, P. gingivalis GroEL immunization was reported to significantly reduce the 
levels of alveolar bone loss induced by multiple periodontopathic bacteria in an 
animal model (216). Finally, the presence of oxidoreductases and various chaperone 
proteins in the EPM of oral bacteria biofilms is not only of interest regarding 
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periodontal diseases, but also for possible associations of bacterial biofilms with 
systemic inflammatory and autoimmune diseases (217-219). 
Twenty-five of the proteins detected in the EPM of P.gingivalis biofilm were 
previously identified as outer membrane vesicles’ (OMV) proteins (85). P. gingivalis 
is able to specifically concentrate and release a large number of its virulence factors 
into the environment in the form of OMV, and these vesicles have been linked to 
biofilm formation for example in Helicobacter pylori (220). Our results show that 
P.gingivalis OMV proteins represent a significant portion of the EMP proteome and 
OMV are therefore likely contributors to the biofilm development. An example of P. 
gingivalis OMV protein identified both in mono- and dual-species EPMs was 
hemagglutinin HagA, a surface protein that can function as an adhesin attaching 
bacteria to the host cells (82). We identified several other P. gingivalis virulence 
proteins in the biofilm matrix, such as fimbriae that are key factors in adhesion of the 
bacterial cells to the host tissue, its colonization and invasion of host cell membranes 
(221). Another virulence protein that contributes to the destruction of periodontal 
tissues is Lys-gingipain (kgp), and in our dataset, it was one of the most abundant P. 
gingivalis EPM proteins. Gingipains degrade collagen and fibronectin and inhibit 
interactions between host cells and the extracellular matrix. In addition, they degrade 
various cytokines, resulting in a disruption of the host cytokine network (221).  
Another P. gingivalis protein identified both in mono- and dual-species EPM was 
PGN_0898, a bacterial peptidylarginine deiminase (PAD) (Additional file 2: Table 
S1). It gives P. gingivalis a unique ability to citrullinate proteins (222). Citrullinated 
bacterial and host peptides may cause an autoimmune response in rheumatoid arthritis 
(222, 223).  
                Sequence-based prediction of the proteins subcellular localization is an 
important part of the identified proteome description and an essential step in the 
search for novel vaccine or drug targets (224, 225). Our data provided evidence that 
the matrix proteome consists of secreted proteins, proteins from cell debris, and 
OMPs. The prediction of OMPs in this study was of particular importance due to their 
involvement in adhesive properties and coaggregation of F. nucleatum and P. 
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gingivalis with other bacteria, as well as attachment to host cells. The latter 
interaction has significance both in the pathogenesis of infection and in the immune 
response of the host (225). The SOSUI-Gram and BOMP tools identified 40 and 42 
OMPs, respectively, and there was variation in the prediction outcomes of the two 
bioinformatics methods. This observation illustrates that the use of several 
bioinformatics methods is both beneficial and necessary, and cross-referencing with 
available literature should complement the importance of the predictions. The BOMP 
tool specifically predicts membrane proteins containing β-barrel integral domains, 
which can have many different functions including enzymatic, transport and structural 
support (226). An example of such OMP is FomA (FN1859) which was identified in 
both mono- and dual-species EPM (Table 4). It is a nonspecific porin which acts as a 
virulence factor, and a major antigen of F. nucleatum (227, 228) that plays a role in 
binding to P. gingivalis (229). FomA of F. nucleatum represents a potential target 
protein for the prevention of bacterial co-aggregation by vaccination (229, 230). 
Other detected putative F. nucleatum virulence factors were auto-transporter 
fusobacterium outer membrane protein (FN1526) and serine protease (FN1426). Both 
proteins are involved in protein secretion pathways (205), and the latter has peptidase 
and hydrolase activity, which allows degradation of fibronectins, fibrinogens and 
collagens. The capacity of F. nucleatum to degrade proteins of the extracellular 
matrix of host connective tissues has been described as a significant contributor to 
invasion of the gingival tissue and subsequent damage of periodontal tissues (205, 
231). 
Proteomic comparisons between different growth conditions 
The bacterial proteins show fluctuations under different conditions of growth, i.e. in 
biofilm, planktonic, mono-species and dual-species settings, and the regulated 
proteins have various and complex functional classifications.  
The most abundant proteins have functions as oxidoreducatases, acyltransferases, 
outer membrane proteins and proteases among others. Levels of a number of 
virulence factors were among the most abundant proteins under both biofilm and 
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planktonic growth conditions. Some of these proteins were shown to be abundant in 
the extracellular polymeric matrix of the biofilms (204). Proteins involved in vitamin 
B1 (Thiamine) and vitamin B2 (Riboflavin) metabolic processes were among those 
significantly increased in F. nucleatum biofilms. It was not previously known if 
vitamin B1 or B2 were aiding in biofilm formation, but Thermotoga maritima biofilm 
cells exhibited increased transcription of genes involved in biosynthesis of thiamine 
(232). As in F. nucleatum biofilm, riboflavin biosynthesis protein (RibBA or 
PGN_0643) was also increased in the P. gingivalis biofilm. This agrees with a 
transcriptomic study that showed this protein to be upregulated in a P. gingivalis 
biofilm (233). 
Interestingly, the FadA adhesion protein (FN0249) displayed an almost 8-fold 
reduction in the dual-species biofilm compared to the planktonic state, but showed no 
change in the mono-species cultures. This adhesion protein helps F. nucleatum to 
adhere and invade host epithelial and endothelial cells (234) and promotes colorectal 
carcinogenesis by modulating E-cadherin/b-catenin signaling (113). In a recent study, 
P. gingivalis suppressed the invasion of F. nucleatum in gingival epithelial cells (235) 
and this was attributed to the degradation of E-cadherin by P. gingivalis gingipains, 
which has been previously reported (236). This work also suggests that P. gingivalis 
effects the FadA protein in addition to the E-cadherin.  
When comparing mono-species to dual-species protein levels, results indicate 
minimal changes in the F. nucleatum protein levels in biofilm and in planktonic 
growth conditions. The majority of P. gingivalis proteins that show changes in the 
dual species growth condition showed reduction under both biofilm and planktonic 
settings, that confirmed the finding that shows how community provides favorable 
environment to P. gingivalis and reduces its stress (141) 
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6. Conclusion and future perspectives  
In conclusion, in this study we demonstrated that proteins and carbohydrates are the 
major components in the EPM of in vitro grown biofilms of F. nucleatum and P. 
gingivalis; however, eDNA might also play a role in the structure of the biofilm. 
More structural and functional studies of EPM of subgingival biofilms are still needed 
to identify new targets to control biofilm growth. Improved models with more 
complex systems that involve in vivo studies are clear objectives for further work. 
Proteins in the extracellular matrix of biofilms formed by the oral bacteria F. 
nucleatum and P. gingivalis have different functional classifications. Potential 
virulence proteins, outer membrane proteins and various binding proteins (DNA-
binding, ATP-binding, and metal ion binding) were among the abundant proteins 
identified in the biofilm EPM. These proteins represent potential candidates that 
might be targeted for the inhibition of biofilm development. Furthermore, 
identification and quantification of these proteins will provide a molecular basis for 
their role in the formation of EPM. This might contribute to an understanding of the 
role played by F. nucleatum and P. gingivalis in the development of periodontal and 
systemic diseases, and lead to improved treatment options for these diseases. 
The dynamics of bacterial proteins’ representation in biofilm, planktonic, mono-
species and dual-species settings is influenced by the different conditions of bacterial 
growth. Different bacterial functions show changes in protein levels as conditions 
change, for instance increased vitamin B synthesis in F. nucleatum and P. gingivalis 
biofilms, and increased translation and binding proteins in the dual species biofilms. 
In general, P. gingivalis showed greater protein changes compared to F. nucleatum in 
both settings (biofilm vs planktonic and mono-species vs dual-species setting). When 
dual-species were compared between biofilm and planktonic growth conditions, P. 
gingivalis had fewer changes, suggesting their dependency on F. nucleatum, which 
showed greater proteomic changes.  
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Based on these results, we conclude that adding another bacteria to the environment 
can trigger changes in the protein levels; this can be seen when bacteria grow in 
biofilm or in the planktonic state. Thus proteomic studies of multispecies biofilms are 
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Background: Biofilms are organized communities of microorganisms embedded in a self-produced
extracellular polymeric matrix (EPM), often with great phylogenetic variety. Bacteria in the subgingival
biofilm are key factors that cause periodontal diseases; among these are the Gram-negative bacteria
Fusobacterium nucleatum and Porphyromonas gingivalis. The objectives of this study were to characterize the
major components of the EPM and to test the effect of deoxyribonuclease I (DNase I) and proteinase K.
Methods: F. nucleatum and P. gingivalis bacterial cells were grown in dynamic and static biofilm models.
The effects of DNase I and proteinase K enzymes on the major components of the EPM were tested during
biofilm formation and on mature biofilm. Confocal laser scanning microscopy was used in observing biofilm
structure.
Results: Proteins and carbohydrates were the major components of the biofilm matrix, and extracellular DNA
(eDNA) was also present. DNase I and proteinase K enzymes had little effect on biofilms in the conditions
used. In the flow cell, F. nucleatum was able to grow in partially oxygenated conditions while P. gingivalis
failed to form biofilm alone in similar conditions. F. nucleatum supported the growth of P. gingivalis when
they were grown together as dual species biofilm.
Conclusion: DNase I and proteinase K had little effect on the biofilm matrix in the conditions used.
F. nucleatum formed biofilm easily and supported the growth of P. gingivalis, which preferred anaerobic
conditions.
Keywords: Subgingival biofilm; extracellular polymeric matrix; Fusobacterium nucleatum; Porphyromonas gingivalis;
static and dynamic biofilm models; confocal laser scanning microscopy
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A
biofilm has been defined as a structured commu-
nity of bacterial cells enclosed in a self-produced
extracellular polymeric matrix (EPM) and ad-
herent to an inert or living surface (1). All biofilms share
several common features  these include the production
of extracellular polymeric substances (EPS), which are
hydrated biopolymers secreted by bacteria. The biopoly-
mers surround and immobilize microbial aggregates,
make the macroscopic appearance of biofilms, and are
frequently referred to as ‘slime’ (2).
In general, it is estimated that the microorganisms
account for less than 10% of the dry weight of the
biofilms, whereas the matrix can account for more than
90% (2). The EPM increases resistance to host defences
and antimicrobial agents, compared with more vulnerable
free-floating (planktonic) cells, and it forms a hydrated
barrier between cells and their external environment. The
function of the matrix includes adhesion, aggregation of
microbial cells, cohesion of biofilm, retention of water,
sorption of organic and inorganic material, enzymatic
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activity, nutrient source, exchange of genetic information,
and export of cell components (2).
The EPM is chemically complex, varying with respect
to bacterial species/strains and culture conditions (2, 3).
Extracellular polysaccharides and proteins have been
shown to be the key components of the matrix (2). Recent
studies also indicate that extracellular DNA (eDNA)
plays an important role in the establishment of biofilm
structure (36). Some studies showed that removing
eDNA reduces initial adhesion and aggregation of
bacteria to surfaces (7, 8), and others have shown that
eDNA is a major matrix component in some species
biofilm (9), including Pseudomonas aeruginosa biofilm
(10), where eDNA seems to induce antibiotic resistance
(11). In Staphylococcus aureus biofilm, it was shown
that cell lysis and the presence of eDNA were critical
for attachment of biofilm during the initial stages
of development and during biofilm maturation (12).
Characterization of EPM components is mandatory in
understanding biofilm structure and function. However,
efficient EPM isolation is demanding because the isola-
tion procedures might damage the cells causing contam-
ination. Enzymatic treatment of biofilm was found to
be helpful in the extraction of biofilm matrix, with no
noticeable cell lysis (13, 14). Proteinase K is one of the
enzymes that is used or included in the enzymatic
extraction methods to degrade proteins in the matrix to
increase nucleic acid release (14, 15).
Dispersal of biofilms by enzymes has been used in
recalcitrant biofilms (e.g. using DNase I) on P. aeruginosa
biofilms in cystic fibrosis patients (16). Treatment of
biofilms with DNase I has also been shown to enhance
the effect of antibiotics (17).
Oral bacterial biofilms are the key factors in the etiology
of dental caries and periodontal diseases. The diversity,
complexity, and multispecies community of the oral
biofilm have been extensively reviewed (18, 19), but are
still not fully clarified.
Fusobacterium nucleatum and Porphyromonas gingivalis
are among the important species in the oral biofilm
involved in the pathogenesis of periodontitis (20).
F. nucleatum is commonly cultivated from the subgingival
plaque from periodontitis patients, and because of its
ability to aggregate with many oral bacteria, it works as a
bridge between early and late colonizers in the dental
biofilm (21). P. gingivalis is a member of the Socransky’s
red complex (bacteria strongly associated with period-
ontal disease) and has many virulent factors such as
fimbriae, lipopolysaccharides, cysteine proteinases, and
end products of metabolism (22).
The aim of this study was to characterize EPM main
components and to analyse the effects of DNase I and
proteinase K on early and mature biofilms formed by
F. nucleatum and P. gingivalis. Confocal laser scanning
microscopy (CLSM) was used in structural studies
applying dynamic and static biofilm models.
Materials and methods
Bacteria and growth medium
Fusobacterium nucleatum subsp. nucleatum, strain ATCC
25586 and P. gingivalis type strains ATCC 53978 (W50),
ATCC 33277, and ATCC BAA-1703 (FDC 381) were
used in the current study.
The bacteria were grown on fastidious anaerobic agar
(FAA) plates at 378C in anaerobic condition (5% CO2,
10% H2, and 85% N2) (Anoxomat System, MART
Microbiology, Lichtenvoorde, The Netherlands) for 48 h
and then inoculated in liquid medium prepared with the
following: tryptone (Oxoid Ltd., London) (15 g/L); NaCl
(5 g/L); KH2PO4 (1.5 g/L); Na2HPO4 ×2H2O (3.5 g/L);
NaHCO3 (0.5 g/L); and yeast extract (Oxoid) (3.0 g/L).
Filter sterilized ascorbic acid (1 mg/L), vitamin B12
(0.1 mg/L), glucose (5.5 g/L), and hemin (5 mg/L) were
added to the autoclaved part of the medium (23). The
bacteria were incubated for 24 h at 378C in anaerobic
conditions and were used as the source of culture in-
oculum in the dynamic and static biofilm models
(see beneath).
The flow cell biofilm
Biofilms were grown at 378C in three-channel flow cells
with individual channel dimensions of 1440 mm. The
flow system was assembled and prepared as described by
Christensen et al. (24). A glass cover slip (2450 mm)
(product # 1014; Assistant, Sondheim/Rhön, Germany)
was used as substratum for biofilm growth. Before each
experiment was carried out, the flow cell system was
autoclaved, and after assembling, the systemwas sterilized
by pumping a 0.5% (wt/vol) hypochlorite solution into the
system and leaving it there for 4 h. The system was flushed
with 2 L of sterile water. The flow chamber was then filled
overnight with media at 378C to let the system equilibrate
with the medium. Inocula were prepared as follows:
bacteria grown for 48 h on FAA plates were re-suspended
in liquid media and incubated overnight at 378C. After
adjusting the optical density at 550 nm to 0.5, aliquots of
250 ml cultures were injected into each channel of the flow
cell after stopping the medium flow and clamping off
the silicon tubing to prevent back flow into the system.
The flow cell was inverted for 1 h to allow for adhesion of
cells to the glass surface without flow. The flow was then
resumed and the clampswere removed. During the growth
of biofilms, the fresh medium was pumped through
the flow cells at a constant rate of 3.3 ml/h/channel by
using a peristaltic pump (model 205S; Watson-Marlow,
Falmouth, UK) (25).
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The biofilm for EPS extraction
Petri dishes with 9 cm diameter (Nunc, Rochester,
NY, USA) each containing 20 ml of liquid medium
were inoculated with 100 ml of bacterial suspension
(OD550nm1). The dishes were incubated in anaerobic
conditions (without shaking) at 378C for 5 days. The
medium was then removed and the biofilm samples were
washed twice with phosphate-buffered saline (PBS)
before being harvested by scraping with a cell scraper
(Nunc, Rochester, NY, USA). The biofilm samples
were suspended in 1 ml PBS and stored at 208C until
processing.
Enzymatic treatment of harvested biofilm
The biofilm samples were homogenized with FastPrep
FP120 Thermo Savant homogenizer (Qbiogene, Cedex,
France) at a speed of 4 m/sec for 20 sec, then Proteinase K
was added to 500 ml of each sample to a final concentra-
tion of 5 mg/ml as described (14, 26). Samples with added
distilled water were used as controls. Enzyme treated
samples and controls were incubated at 378C for 1 h. After
enzymatic treatment, the biofilm samples and controls
were filtered through 0.2 mm pore size acrodisc syringe
filters (Pall, BioSciences, Ann Arbor, MI, USA). Aliquots
from the eluate were used for quantification of proteins
and carbohydrates and extraction of DNA.
Protein concentration assay
For measurement of the protein concentration, the
samples and controls were diluted 10 times in distilled
water, and then 0.5 ml of Lowry reagent was added to 0.5
ml of sample dilution. After 20 min at room temperature,
0.5 ml of Folin and Ciocalteu’s phenol reagent working
solution (Sigma-Aldrich, MO, USA) were added to the
mixture and left for another 30 min at room temperature
(25). The absorbance of the standards and samples were
measured at 750 nm and compared to a standard curve
obtained by serial dilution of bovine serum albumin.
Carbohydrate assay
The carbohydrate concentration in EPM was measured
by the anthrone method with the modifications described
by Raunkjær et al. (14, 27), using glucose as a reference
standard. The samples and controls were prepared by 10
times dilution in distilled water, and then 100 ml of each
dilution was mixed with 200 ml of anthrone reagent
(0.125% anthrone [wt/vol] in 94.5% [vol/vol] H2SO4).
Samples and controls were placed in a water bath at
1008C for 14 min and then cooled at 48C for 5 min. The
absorbance at 595 nm was measured using microtitre
plate reader (Multiskan MS Type 352, Labsystems,
Finland).
eDNA extraction and quantification
Extraction of eDNAwas performed using Fast DNA spin
kit (MP Biomedicals, Solon, OH, USA) according to the
manufacturer’s instructions. Measurements of DNA
concentration in 500 ml from each sample were carried
out using a NanoDrop spectrophotometer (Thermo
Fisher Scientific Inc. Waltham, MA, USA).
The eDNAwas electrophoresed on an 0.8% agarose gel
from SeaKem (FMC BioProducts, Rockland, ME, USA)
and stained with GelRedTM (Biotium, Hayward, CA,
USA) using 0.5TBE buffer at 100 V for 40 min. EZ
load 100-bp molecular ruler (Bio-Rad, CA, USA) was
used as DNA standard.
Static biofilm microtitre plate assay
Ninety-six Well Black with Clear Flat Bottom Polystyr-
ene Not Treated Microplates (cat. no. 3631, Corning, NY,
USA) were used to grow biofilms. The effect of the
enzymes was evaluated on biofilm formation and mature
biofilm (26). Deoxyribonuclease I (DNase I) (Sigma-
Aldrich, MO, USA) from bovine pancreas was prepared
in an enzyme buffer (0.15 mM NaCl and 5 mM MgCl2),
and proteinase K (Sigma-Aldrich, MO, USA) was
prepared in distilled water. The two enzymes were used
in different concentrations (0.125, 0.25, 0.5, and 1 mg/
ml). The enzyme buffer (for DNase I) and distilled water
(for proteinase K) were used for the controls. The
bacteria were prepared by diluting overnight grown
bacterial cultures to prepare suspensions of 1.2107
cfu/ml.
A total of 200 ml from the bacterial suspension was
used in each well of the microplates to grow biofilm. For
dual species biofilm, equal amounts (100 ml) from each
bacterium were used.
To evaluate the effect of DNase I and proteinase K on
biofilm formation, the enzymes were added and then the
microplates were incubated in anaerobic conditions at
378C for 48 h. To evaluate the effects on mature biofilm,
a 48-h-old biofilm was washed with PBS, and then the
enzymes were added in their respective buffers and
incubated for 1 h at 378C.
The medium and enzymes were removed, and the wells
were washed once with distilled water. The biofilm was
then stained with 150 ml of crystal violet (0.5%) for 15
min, the stain was removed, and the biofilm was washed
twice with distilled water and left to dry. To solubilize the
stain, 150 ml of 95% ethanol was added to each well, and
the absorbance was read at 570 nm in an automatic
ELISA microplate reader (Multiskan MS Type 352,
Labsystems, Finland).
CLSM was used to visualize the effect of enzymes on
biofilm formation and on mature biofilm. In brief, the
biofilm was grown in m-clear bottom, chimney well,
surface treated, sterile 96 Well Microtitre plates (cat. no.
635090, Greiner Bio-One, Frickenhausen, Germany)
Characterization of extracellular polymeric matrix
Citation: Journal of Oral Microbiology 2013, 5: 20015 - http://dx.doi.org/10.3402/jom.v5i0.20015 3
(page number not for citation purpose)
under the same conditions as described above. The
concentrations of DNase I and proteinase K used on
the biofilm examined by CLSM were 1 mg/ml.
CLSM of biofilms in flow cells and microtitre plates
The biofilms were examined by Zeiss LSM 510 META
equipped with a water-immersion of 63 objective (Carl
Zeiss, Jena, Germany). The biofilms were stained for
15 min with 100 ml LIVE/DEAD BacLight Bacterial
Viability Kit (Invitrogen Corporation, NY, USA). The
final concentrations of Syto-9 and propidium iodide (PI)
were 0.01 mM and 0.06 mM, respectively. The SYPRO†
Ruby biofilm matrix stain (Invitrogen Corporation, NY,
USA) was used to stain proteins in the EPM. The green
fluorescence and red fluorescence of SYTO 9 and PI were
excited using an argon laser beam, with excitation lines
at 488 nm and a helium/neon at 543 nm, respectively.
The SYPRO† Ruby stain was excited at 405 nm with
diode laser. The CLSM image stacks were analysed by
the image-processing software COMSTAT (28). The bio-
mass, average thickness, and maximum thickness were the
parameters used to compare different biofilms.
Statistical analyses
The software package IBM SPSS 19.0 was used for the
statistical analyses. The means and standard deviations of
carbohydrates and eDNA concentrations in harvested
biofilms that had been treated with proteinase K were
calculated, and MannWhitney U-test was used to
compare the means. The means and standard deviation
of absorbance values representing the effect of DNase I
and proteinase K on early biofilm formation or mature
Fig. 1. (A) Biomass and maximum thickness of Fusobacterium nucleatum ATCC 25586 (F.n) when grown alone or together with
Porphyromonas gingivalis W50 (P.g) biofilm and calculated from one point z-stack confocal microscopy images taken from the
middle of the flow cell and analysed by COMSTAT software program. (B) Representative CLSM images of 24-h- (left), 48-h-
(middle), and 72-h- (right) old biofilms showing mutualistic growth of F. nucleatum ATCC 25586 and P. gingivalis W50 (upper)
compared to mono-species F. nucleatum ATCC 25586 (lower). The biofilms were grown in flow cells and were stained with Cyto9
(green) and propidium iodide (red).
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biofilm were calculated for each enzyme concentration
and each tested biofilm. Multiple comparisons within
groups were performed by the KruskalWallis test, and, if
significant, the MannWhitney U-test was used as a post
hoc test. The significance level was set to pB0.05.
Results
Biofilm growth in flow cell
F. nucleatum was able to form biofilm in partially
oxygenated conditions where the biofilm developed
shortly (24 h) after inoculation. P. gingivalis failed to
form biofilm alone in similar conditions. However, the
growth of P. gingivalis was initiated when grown together
with F. nucleatum. Biofilm formation and maturation
were enhanced by co-culture of the two species (Fig. 1A
and B).
The CLSM images revealed irregular topography of
the biofilm, without clear mushroom-shaped structure
(Figs. 1B and 2). The biofilm thickness after 3 days of
cultivation ranged from 2030 mm in our experimental
setting.
The EPM major components
The EPM components were extracted from the static
biofilm. Proteins and carbohydrates were major compo-
nents of the biofilm matrix, and the protein concentration
in the samples of the extracellular biofilm ranged from
374 to 982 mg/ml, with an average of 666 mg/ml, and for
carbohydrate, the concentration ranged from 348 mg/ml
to 990 mg/ml, with an average of 682 mg/ml. For DNA,
the concentration ranged from 17 to 46 mg/ml, with an
average of 25 mg/ml.
Chemical analysis of EPM showed that the contents of
proteins and carbohydrates were highest in EPM ex-
tracted from F. nucleatum and P. gingivalis W50 biofilm
and lowest in F. nucleatum and P. gingivalis FDC381
biofilm (Fig. 3).
Proteins in the EPMof the dual speciesF. nucleatum and
P. gingivalis biofilm grown in flow cells were visualized by
CLSM after staining with Live/Dead and SYPRO† Ruby
biofilm matrix stain, and it showed abundant amounts of
proteins distributed within the biofilm matrix (Fig. 2).
No statistical significant differences were found in the
concentrations of carbohydrates and eDNA between
Proteinase K-treated and non-treated harvested biofilms
(Fig. 3). The extracted DNAwas analysed by agarose gel
electrophoresis and the size of eDNA was found to be
around 100 bp as shown (Fig. 4).
Enzyme effect on biofilm formation and mature
biofilm
To test the effect of DNase I and proteinase K on biofilm
formation, the enzymes were added at time zero, and the
biofilm was analysed after 48 h. To test the effect on
mature biofilm, the enzymes were added at 48 h, and the
effect was analysed after 1 h of incubation. F. nucleatum
type strain ATCC 25586 and P. gingivalis type strain
ATCC 33277 were tested when they were grown as a
monoculture or as a dual species culture. In the static
biofilm model (microtitre plates), the effects of these
enzymes were not statistically significant (Fig. 5).
These findings were confirmed by CLSM image ana-
lyses, where bacterial biomass, maximum thickness, and
average thickness of the biofilm were measured (Fig. 6).
These parameters have little or no variation after enzy-
matic treatment, and the biofilm shape and structure
remained unchanged.
Discussion
There is a lack of studies on EPM of subgingival biofilm.
However, exo-polysaccharides in the supragingival bio-
film have been extensively studied and known for a long
time (2931). In the present study, we have isolated
EPM and tested effects of DNase I and proteinase K
on biofilms from periodontal-disease-associated bacteria
grown in vitro.
The EPM of the bacterial biofilms in our study
are characterized by the presence of macromolecular
complexes of carbohydrates, proteins, and nucleic acids.
The enzymatic treatment of the harvested biofilms with
proteinase Kwas performed to find out if it would increase
the liberation of eDNA or carbohydrates, compared with
only vortexing or homogenizing. This treatment did not
result in noticeable difference in the yielded eDNA or
carbohydrates (Fig. 3).Wu andXi found similar results for
carbohydrates in Acinetobacter sp. strain AC811 biofilm
Fig. 2. Representative CLSM image shows proteins in EPM
of 24-h dual species biofilm (Fusobacterium nucleatum
ATCC 25586 and Porphyromonas gingivalis W50) grown in
flow cells. The proteins were stained with SYPRO† Ruby
stain (blue). Sideviews, XZ (top) and YZ (right) are sagittal
sections of the biofilm. Scale Bar20 mm.
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matrix, but the eDNA yield was increased after enzyme
treatment (14).
Even though proteins were abundant in the biofilm
matrix of our F. nucleatum and P. gingivalis dual species
biofilm as shown in (Fig. 2), treatment with proteinase
K was shown to be insufficient to disperse the biofilm
matrix. A carbohydrate-rich matrix might be the reason
for this ineffectiveness, which has also been suggested for
Fig. 3. Comparison of (A) carbohydrate and (B) eDNA yields from the biofilm matrix samples treated with proteinase K
enzyme and non-treated samples. The matrix of 5-day-old biofilm was treated with 5 mg/ml proteinase K at 378C for 1 h. F.n,
Fusobacterium nucleatum ATCC 2558; P.g W50, Porphyromonas gingivalis W50; P.g 381, P. gingivalis FDC381; P.g 33277, P.
gingivalis ATCC 33277. The bars represent the means with standard deviations from five samples (carbohydrates) and three
replicates (eDNA).
Fig. 4. Gel electrophoresis (0.8% agarose gel) of the extracellular DNA. The eDNAwas extracted from the matrix of 5-day-old
biofilm of these species. F.n, Fusobacterium nucleatum ATCC 25586; P.g W50, Porphyromonas gingivalis W50; P.g 381,
P. gingivalis FDC381; P.g 33277, P. gingivalis ATCC 33277. Lane M, EZ load 100-bp molecular ruler (Bio-Rad).
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staphylococcal biofilms (32, 33). The eDNA detected in
the EPM in our biofilms had a size around 100 bp, as
demonstrated with agarose gel electrophoresis (Fig. 4).
This size is usually higher than described for other
biofilms; however, the size of the eDNA has been
reported to range from less than 100 bp to 10 kb (34).
Targeting the eDNA with DNase I in the mono or dual
species biofilm matrix in our study gave no obvious
effects with respect to prevention of biofilm formation or
dispersion of mature biofilm. This is in contrast to
enzymatic treatment of P. aeruginosa biofilm (4). One
suggested function of eDNA is in gene transfer (35, 36).
The biofilm may offer an excellent milieu for DNA
exchange, as the cells are in close juxtaposition and
DNA can be trapped within the extracellular matrix
(37). Genus Fusobacterium and other genera of oral
bacteria contain conjugative transposons that facilitate
the DNA transfer between bacteria through conjugation.
Fig. 5. Effect of DNase I and proteinase K on the biofilm formation (time zero) and on 48-h-old biofilm. Fusobacterium
nucleatum type strain ATCC 25586 (F.n) and Porphyromonas gingivalis type strain ATCC 33277 (P.g 33277) bacterial species
were tested when they were grown as monoculture or as dual species culture. (A) DNase I effect on biofilm formation, (B)
DNase I effect on 48-h biofilm, (C) Proteinase K effect on biofilm formation, (D) Proteinase K effect on 48-h biofilm. The
colored columns refer to the enzyme concentrations (0.125, 0.25, 0.5, and 1 mg/ml). The y-axis represents absorbance at 570 nm.
The bars represent the means with standard deviations for 35 samples.
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P. gingivalis also shows a large degree of variation
between strains, proposing that this organism has gone
through frequent genetic rearrangements (37, 38).
In this study, we have shown that F. nucleatum can
grow in a flow cell biofilm model in a non-strictly
anaerobic environment, while this was not true for P.
gingivalis. It seems to be a synergistic enhancement in the
biofilm formation when these two species are grown
together even in a partially oxygenated condition, which
indicates that F. nucleatum might have the capacity to
protect P. gingivalis from oxidative stress. This has also
been reported in other studies (39, 40). Nearby in vivo
association between these two microorganisms might
indicate that they support each other, as shown in biofilm
and mouse models (41, 42). F. nucleatum and P. gingivalis
have been found to co-aggregate in vitro and in vivo,
which could play a role in biofilm formation and
pathogenesis, as also reported from mouse model experi-
ments (43).
In general, a better understanding of the EPM of
subgingival biofilm and complex multispecies biofilms
should lead to more efficient control strategies. The man-
agement of biofilm growth does not necessarily require
direct killing of the bacteria in the biofilm, but it might be
directed toward degradation or dispersal of the biofilm
matrix to reverse the biofilm mode of growth to a
planktonic state, which is significantly easier to treat
and manage, for example, by antibiotics.
In conclusion, in this study, we demonstrate that
proteins and carbohydrates are major components in
the EPM biofilms of F. nucleatum and P. gingivalis grown
in vitro; however, eDNA might also play a role in the
structuring of the biofilm. More detailed structural and
functional studies of EPM of subgingival biofilms are
needed to identify and to attack new targets to control
biofilm growth. Improved models and more complex
systems and in vivo studies are clear objectives for further
work.
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a b s t r a c t
The Gram-negative bacteria Fusobacterium nucleatum and Porphyromonas gingivalis are members of a
complex dental biofilm associated with periodontal disease. In this study, we cultured F. nucleatum and
P. gingivalis as mono- and dual-species biofilms, and analyzed the protein composition of the biofilms
extracellular polymeric matrix (EPM) by high-resolution liquid chromatography-tandem mass spec-
trometry. Label-free quantitative proteomic analysis was used for identification of proteins and
sequence-based functional characterization for their classification and prediction of possible roles in
EPM. We identified 542, 93 and 280 proteins in the matrix of F. nucleatum, P. gingivalis, and the dual-
species biofilm, respectively. Nearly 70% of all EPM proteins in the dual-species biofilm originated
from F. nucleatum, and a majority of these were cytoplasmic proteins, suggesting an enhanced lysis of
F. nucleatum cells. The proteomic analysis also indicated an interaction between the two species: 22
F. nucleatum proteins showed differential levels between the mono and dual-species EPMs, and 11
proteins (8 and 3 from F. nucleatum and P. gingivalis, respectively) were exclusively detected in the dual-
species EPM. Oxidoreductases and chaperones were among the most abundant proteins identified in all
three EPMs. The biofilm matrices in addition contained several known and hypothetical virulence pro-
teins, which can mediate adhesion to the host cells and disintegration of the periodontal tissues. This
study demonstrated that the biofilm matrix of two important periodontal pathogens consists of a
multitude of proteins whose amounts and functionalities vary largely. Relatively high levels of several of
the detected proteins might facilitate their potential use as targets for the inhibition of biofilm
development.
© 2017 Elsevier Ltd. All rights reserved.
1. Background
Most bacterial species can adopt either a single-cell planktonic
lifestyle or a multicellular state, i.e. community lifestyle with
bacterial cells anchored to one another and to surfaces in an or-
dered structure known as a biofilm [1,2]. However, much of what is
currently known about bacteria has been obtained from free-
floating bacteria that grow in suspension [1], which can have
considerably different gene expression pattern from sessile bacteria
[3]. Bacterial biofilms play significant roles in human infections and
diseases, and it is estimated that 65e80% of themicrobial infections
are caused by bacteria adhered to surfaces [4]. These biofilms also
have an important role in increasing bacterial resistance to
antibiotics [4]. In biofilms, poor antibiotic penetration, nutrient
limitation, slow growth, adaptive stress responses, and formation
of persister cells are assumed to establish a multi-layered defense
[5]. An extracellular matrix provides the biofilms with their
macroscopic appearance and can account for more than 90% of the
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whole biofilm dry weight [6]. It is usually composed of poly-
saccharides, proteins and extracellular DNA and lipids, which
altogether are called extracellular polymeric matrix (EPM) [7].
Periodontitis, which is defined as inflammation of the gingiva
extending into the whole periodontium, is a classic example of
biofilm mediated diseases [8]. It starts in a mild form called
gingivitis, which is highly prevalent, and can affect up to 90% of the
worldwide population. However, gingivitis does not affect the un-
derlying supporting structures of the teeth and is reversible. On the
other hand, more severe periodontitis can result in loss of con-
nective tissue and bone support and is a main cause of tooth loss in
adults [9]. Fusobacterium nucleatum and Porphyromonas gingivalis
are among the important species in the subgingival biofilm that are
involved in the pathogenesis of periodontitis [10]. F. nucleatum is
frequently cultivated from the subgingival biofilm, and because of
its ability to aggregate with many oral bacteria, it works as a bridge
between early and late colonizers in the development of dental
biofilm [11]. P. gingivalis is a member of the Socransky's red com-
plex (i.e. bacteria strongly associated with periodontal disease) and
has many virulence factors such as fimbriae, lipopolysaccharides,
cysteine proteinases, and end-products of metabolism [12].
We have previously shown that EPM of a biofilm composed of
F. nucleatum and P. gingivalis is prosperous with proteins [13]. In
general the proteins in EPM are lectins, sugar binding proteins
which enable cell-to-cell or cell-to-matrix interactions [14], and
auto-transporters. The latter group is a family of outer membrane
and secreted proteins of Gram-negative bacteria that possess
unique structural properties facilitating their independent trans-
port across the bacterial membrane to the cell surface, and may
work in adhesion, aggregation, invasion, biofilm formation and
toxicity [15,16]. In addition, pili and fimbriae are proteinaceous
appendages that can contribute to the structure of the biofilm
matrix, and were previously shown to be up-regulated in different
biofilms compared to planktonic cultures [15,17].
In this study, we used a label-free quantitative proteomic
approach for identification and relative quantification of proteins in
the EPM of F. nucleatum and P. gingivalis when grown in mono- or
dual-species biofilms. We report changes in the abundance of EPM
proteins that depend on whether the bacteria have been grown in
mono- or dual species biofilm.
2. Methods
2.1. Bacteria and growth medium
Fusobacterium nucleatum subsp. nucleatum type strain ATCC
25586 and Porphyromonas gingivalis type strain ATCC 33277 were
used in the current study. The bacterial strains were grown on
fastidious anaerobic agar (FAA) plates at 37 !C in anaerobic condi-
tions (5% CO2, 10% H2, and 85% N2) (Anoxomat System, MART
Microbiology, Lichtenvoorde, Netherlands) for 48 h. A few colonies
of each species were then used to inoculate Brucella broths (Becton
Dickinson, Sparks, MD, USA) supplemented with 5 mg/ml hemin
and 0.25 mg/ml vitamin K. The bacteriawere grown overnight in the
liquid medium at 37 !C in anaerobic conditions. The overnight
cultures were adjusted to an absorbance of 0.15 at 600 nm (A600),
whereof 10 ml was transferred to a separate 25 cm2 (area) poly-
styrene cell culture flask (cat.no 90026, TPP, Trasadingen,
Switzerland) to prepare mono species biofilms, and 5 ml from each
species was transferred to prepare dual species biofilm. We
cultured the biofilms in an in vitro static biofilm model [18], the
flasks were incubated at 37 !C in anaerobic conditions for 4 days
without any additional supply of fresh medium. After medium
removal, the biofilm samples were washed once with phosphate
buffered saline (PBS) to remove free-floating bacteria and the
attached biofilm was harvested with a cell scraper (Nunc, Roches-
ter, NY, USA). The collected biofilms were then resuspended in
500 ml PBS and stored at "20 !C until further processing.
2.2. Biofilm viability by colony forming unit (CFU) counting
The viability of the bacterial cells was determined by CFU
counting of the initial inoculum and of the mature 4 days-old
biofilm. Three independent biological replicates were serially
diluted, selected dilutions plated on FAA medium, and incubated
anaerobically at 37 !C for 4 days. The colonies formed on the plates
were counted and used for calculating estimated numbers of viable
cells.
2.3. Extraction of EPM
The biofilm samples were mechanically sheared with FastPrep
FP120 Thermo Savant homogenizer (Qbiogene, Cedex, France) at a
speed of 4 m/sec for 20 s, in Eppendorf tubes, without any cell-
disrupting beads, to avoid contamination from cellular proteins.
The samples were then filtered through 0.2 mm pore size acrodisc
syringe filters (Pall, BioSciences, Ann Arbor, MI, USA) to remove
cells and cellular debris [19]. Aliquots from each eluatewere used in
further work. Direct Detect® Spectrometer (Merck Millipore,
Darmstadt, Germany) was used for protein concentration mea-
surements. Low concentration samples of P. gingivalis EPM were
concentrated by using Amicon Ultra-0.5 centrifugal filter devices
with 3 K Da cutoffs (Merck Millipore, Darmstadt, Germany).
2.4. Sample preparation for the proteomic analysis
In order to generate a statistically robust proteomic dataset,
samples with EPM extracts of mono- and dual-species biofilms
from different culture flasks were prepared in four biological rep-
licates. Filter Aided Sample Preparation (FASP) method developed
by Wisniewski and co-workers [20], was used with minor modifi-
cations for the samples processing. Briefly, EPM samples were
mixed in a solution of 10 mM dithiothreitol (DTT) in 100 mM
ammonium bicarbonate (NH4HCO3) [solution to total protein ratio
(v/w) 1:10] and incubated for 45min at 56 !C. Microcon device YM-
10 filters (Merck Millipore, Darmstadt, Germany) were first condi-
tioned by adding 100 ml of urea buffer (8M urea, 10 mM HEPES, pH
8.0) and centrifuged at 14,000xg for 5 min. This and the following
steps were carried out at room temperature, unless otherwise
stated. Aliquots of EPM samples containing 50 mg of protein were
mixed with 200 ml urea buffer in the filter unit and centrifuged at
14,000xg for 15 min and this step was repeated one more time. The
filtrate was discarded and 100 ml of 0.05 M iodoacetamide was
added to each sample. The samples were mixed at 600 rpm for
1 min in a thermo-mixer and incubated without mixing in the dark
for 20 min, followed by centrifugation at 14,000xg for 10 min, three
washes with 100 ml urea buffer and another three washes with
100 ml 40 mM NH4HCO3 in H2O. EPM remaining on the filter were
digested with trypsin (Thermo Fisher Scientific, IL, USA) in 40 mM
NH4HCO3 buffer [enzyme to protein ratio 1:50 (w/w) ] at 37
!C for
16 h. The released peptides were collected by adding 50 ml of mass
spectrometry grade water followed by centrifugation at 14,000xg
for 15 min. This step was repeated twice. Samples were concen-
trated (to 20e40 ml volume) in a vacuum concentrator (Eppendorf,
Hamburg, Germany).
2.5. Filtration and desalting
StageTips for filtration and desalting were prepared by packing
3M Empore C18 extraction disks (3M, MN, USA) in 200 ml pipet tips
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by a blunt ended needle and a plunger or metal rod that helped to
fit the extracted disks in the pipet tips, according to the protocol
developed by Rappsilber and colleagues [21]. The disks were
wetted by passing 20 ml of methanol, followed by 20 ml of elution
buffer [80% acetonitrile (ACN), 0.1% formic acid (FA)]. The disks
were then conditioned and equilibrated with 20 ml of 0.1% FA just
before the last residue of the previous buffer left the tip to avoid
drying of the disks. Samples (volumes 20e40 ml) were loaded on
top of the Stage Tip. The disks with samples were desalted by
washing with 20 ml of 0.1% FA and were transferred to new tubes.
Peptides were eluted and collected by adding 20 ml elution buffer
two times. The collected samples were dried in the vacuum
concentrator and stored at "80 !C until further analyses. Peptide
samples were resuspended by adding 1 ml of 100% FA and 19 ml of 2%
ACN prior to liquid chromatography-tandem mass spectrometry
(LC-MS/MS) analysis.
2.6. LC-MS/MS
The MS/MS analysis was carried out at the Proteomics Unit,
University of Bergen (PROBE) on an Ultimate 3000 RSLC system
(Thermo Scientific, Waltham, MA, USA) connected to a linear
quadrupole ion trap-Orbitrap (LTQ-Orbitrap) mass spectrometer
(Thermo Scientific) equipped with a nanoelectrospray ion source.
Briefly, 0.5e1 mg protein was loaded onto a pre-concentration col-
umn (Acclaim PepMap 100, 2 cm # 75 mm i. d. nanoViper column,
packed with 3 mm C18 beads) at a flow rate of 5 ml/min for 5 min
using an isocratic flow of 0.1% trifluoroacetic acid, vol/vol (TFA).
Peptides were separated during a biphasic ACN gradient from two
nanoflow UPLC pumps (flow rate of 270 nl/min) on the analytical
column (Acclaim PepMap 100, 50 cm # 75 mm i. d. nanoViper
column, packed with 3 mm C18 beads). Solvent A and B was 0.1% FA
(vol/vol) in water or ACN (vol/vol), respectively. Separated peptides
were sprayed directly into the MS instrument during a 195 min LC
run with the following gradient composition: 0e5 min 5% B,
5e6 min 8% B, 6e135 min 7e32% B, 135e145 min 33e40% B, and
145e150 min 40e90% B. Elution of very hydrophobic peptides and
conditioning of the columnwas performed by isocratic elutionwith
90% B (150e170 min) and 5% B (175e195 min), respectively. Des-
olvation and charge production were accomplished by a nanospray
Flex ion source.
The mass spectrometer was operated in the data-dependent-
acquisition mode to automatically switch between Orbitrap-MS
and LTQ-MS/MS acquisition. Survey of full-scan MS spectra (from
m/z 300 to 2000) were acquired in the Orbitrap with resolution of
R¼ 240,000 at m/z 400 (after accumulation to a target of 1,000,000
charges in the LTQ). The method used allowed sequential isolation
of the most intense ions (up to 10, depending on signal intensity)
for fragmentation on the linear ion trap using collision-induced
dissociation at a target value of 10,000 charges. Target ions
already selected for MS/MS were dynamically excluded for 18s.
General mass spectrometry conditions were as follows: electro-
spray voltage, 1.8 kV; no sheath; and auxiliary gas flow. Ion selec-
tion threshold was 1000 counts for MS/MS, and an activation Q-
value of 0.25 and activation time of 10 ms was also applied for MS/
MS.
2.7. Data analysis
The acquired MS raw data were processed by using the Max-
Quant software [22], version 1.5.2.8, with default settings. Label-
Free Quantification (LFQ) [23] and match between runs, which is
based on retention time alignment between different replicates,
were optional software features, which were used in the MS/MS
data searches. The MS spectra were searched against protein da-
tabases of either F. nucleatum type strain ATCC 25586 or P. gingivalis
type strain ATCC 33277. The respective files were downloaded from
the UniProt knowledgebase on the 4th of February 2015. The mass
spectrometry proteomics data have been deposited to the Proteo-
meXchange Consortium (http://proteomecentral.proteomex-
change.org) via the PRIDE [24] partner repository with the data-
set identifier PXD004888.
Post MaxQuant analysis included filtering of the generated
‘proteingroups.txt’ table for contaminants, only identified by site
and reverse hits by the Perseus software [25]. Each protein iden-
tified in at least two out of four replicates was considered valid. To
discriminate differential expressions of proteins present both in the
mono- and dual-species biofilm, t-test with p-value % 0.05 was
used.
Functional protein annotation was performed by using the
Database for Annotation, Visualization and Integrated Discovery
(DAVID) [26]. Predictions of the identified proteins subcellular
localization were performed by web-based application SOSUI-
GramN [27]. VirulentPred [28] was employed to predict the viru-
lence factors among identified bacterial proteins, and the pre-
dictions were derived from the Cascased SVM (Support Vector
Machine) module [29]. The protein lists were also searched for




Characterization of the biofilms with respect to the amount of
viable cells showed a slight reduction in the numbers of cells in
F. nucleatum biofilms, both when grown alone and with P. gingivalis
(Table 1) compared to the initial inoculum. In the P. gingivalis bio-
film the number of cells was slightly increased after 4 days of
growth, however, in the shared biofilm with F. nucleatum viable
P. gingivalis cells were at equivalent levels as the initial inoculum
(Table 1).
3.2. Biofilm matrix of F. nucleatum is rich in proteins when
compared to P. gingivalis EPM
Trypsin-digested EPM samples from four biological replicates of
the mono- and dual-species biofilms were analyzed by LC-MS/MS.
Searching the acquired MS/MS raw data against either F. nucleatum
or P. gingivalis protein databases resulted in identification of 542
and 93 proteins in the matrix of F. nucleatum and of P. gingivalis,
respectively. In the dual-species biofilm matrix we identified 280
proteins in total, with 198 (70.7%) derived from F. nucleatum and 82
(29.3%) from P. gingivalis (Fig. 1 and Additional file 2: Table S1). The
Table 1
Number of colony forming units (CFU) in the mono- and dual-species biofilms of F. nucleatum and P.gingivalis.
Bacterial species Initial inoculuma (cfu/ml) 4 days mono-species biofilm (cfu/ml) 4 days dual-species biofilm (cfu/ml)
F. nucleatum 2e3 # 107 1e3 # 106 1e2 # 106
P.gingivalis 1e2 # 108 1e4 # 1010 1e2 # 108
The numbers are an average of three biological replicates analysis.
a Absorbance of 0.15 at 600 nm.
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correlation between different biological replicates was highest in
the samples from F. nucleatum EPM (Pearson correlation coefficient
R between 0.89 and 0.99), while somewhat lower for the samples of
P. gingivalis and the dual-species EPM (R between 0.65 and 0.95 and
0.63e0.89 for the EPMs of P. gingivalis and dual-species, respec-
tively) (Additional file 1, Fig. S1A).
3.3. Functional analysis of EPM-associated proteins
We next characterized the identified proteins with respect to
their cellular localization by using a prediction system SOSUI-
GramN. A majority of the proteins originated from the cytoplasm,
with 80% in F. nucleatum EPM and 40% in P. gingivalis EPM (Fig. 2).
For comparison, the percentage of cytoplasmic proteins in the
predicted whole proteomes of F. nucleatum and P. gingivalis is 65%
and 55%, respectively, as determined by using the same software.
The number of proteins with cytoplasmic origin was 68% in the
dual-species EPM. These results suggest an enhanced cell lysis in
the F. nucleatum biofilm, and further support the importance of
dead cell components in the formation of EPMs.
Functional annotation of the identified proteins, which was
extracted from the DAVID database, revealed that F. nucleatum EPM
proteins participated in translation, oxidation/reduction, proteoly-
sis and variousmetabolic processes (Additional file 3: Table S2). The
latter mentioned metabolic proteins could be divided into different
pathways classified by Kyoto Encyclopedia of Genes and Genomes
(KEGG), with the most abundant pathways related to amino acid,
carbohydrate and nucleotide/nucleic acid metabolism. The anno-
tated proteins from P. gingivalis EPM were linked to proteolysis,
cellular homeostasis of ions, and metabolism of amino acids and
nucleobases (Additional file 3: Table S2). Four P. gingivalis proteins
were associated with pathogenesis: major fimbrial subunit protein
FimA, arginine-specific cysteine proteinase RgpA, hemagglutinin
protein HagA and Lys-gingipain [31]. The main biological processes
of proteins detected in the dual-species EPM closely resembled
those described for mono-species EPM proteins (Additional file 3:
Table S2).
Oxidoreductases and chaperones were among the most
Fig. 1. Summary of proteins identifications in the EPMs of two oral bacteria. The
Venn diagram summarizes the number of proteins identified in EPM of F. nucleatum
(Fn) and P. gingivalis (Pg) grown as mono- and dual-species biofilms. The eleven
exclusive proteins in the dual-species EPM included 8 proteins derived from
P. gingivalis and 3 proteins from F. nucleatum (additional file 1: Table S4).
Fig. 2. Predicted subcellular localization of the EPM proteins. Distribution of the identified proteins in the respective EPMs according to their predicted subcellular localization by
SOSUI-GramN: A) F. nucleatum (Fn) EPM; B) P. gingivalis (Pg) EPM and C) Dual-species (FnPg) EPM.
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abundant proteins identified. The results showed that 41 proteins
(7.6%) from the F. nucleatum EPM, 6 proteins (6.5%) in P. gingivalis
EPM and 27 proteins (9.6%) in the dual species EPM were involved
in oxidation/reduction (Additional file 3: Table S2). Six different
chaperone proteins were identified in the EPM of F. nucleatum
including: GroEL (60 kDa chaperonin), DnaK, GroES (10 kDa chap-
eronin), ClpB, HtpG and Fn1610 (33 kDa chaperonin). DnaK and
GroEL were also found in the dual species biofilm matrix (Addi-
tional file 2: Table S1).
3.4. Relative abundances of multiple proteins differ in the mono-
and dual-species EPMs
As the next step we performed quantitative analysis of the
identified proteins based on their LFQ intensity scores. For 87%, 42%
and 41% of all proteins described in the F. nucleatum, P. gingivalis
and the dual-species EPMs, respectively, we determined the rela-
tive abundance (Additional file 4: Table S3). Correlations of LFQ
intensities between the different biological replicas, represented as
R, varied between 0.91 and 0.99, 0.73e0.96 and 0.83e0.95 for
F. nucleatum, P. gingivalis and the dual-species EPMs, respectively
(Additional file 1, Fig. S1B). The quantitative levels of proteins
covered a dynamic range of approximately 10 log2 (Fig. 3). While
the distribution of proteins abundances were similar in the
F. nucleatum and dual-species EPMs (median of log2 LFQ equal to
25.0 and 24.6, respectively), amounts of proteins identified in
P. gingivalis EPM were significantly lower (median of log2
LFQ ¼ 22.1). Top 20 abundant proteins according to the averaged
log2 LFQ are listed in Table 2. Acetyl-CoA acetyltransferase, alkyl
hydroperoxide reductase C22 protein, neutrophil-activating pro-
tein A, tryptophanase and glutamate dehydrogenase were the top
five proteins in the matrix of F. nucleatum biofilm. The oxidore-
ductase NAD-specific glutamate dehydrogenase and the proteolytic
and adhesive protein Lys-gingipain were most abundant in
P. gingivalis EPM. In the dual species EPM, F. nucleatum contributed
to four out of five proteins, and themost abundant was F. nucleatum
glutamate dehydrogenase, while NAD-specific dehydrogenase was
among the most abundant proteins from P. gingivalis. Functional
annotation of top abundant proteins revealed their involvement in
oxidation/reduction, hydrolase activity, proteolysis and binding
(Table 2).
In order to discriminate differential expression of proteins pre-
sent both in the mono- and dual-species biofilm, we performed
two-sample t-test on the corresponding LFQ intensities, with p-
value % 0.05. The LFQ intensities of 22 proteins in F. nucleatum EPM
showed significant changes: three increased and 19 decreased in
the dual-species EPM compared to the mono-species EPM (Fig. 4).
Ethanolamine utilization protein (FN0083), uncharacterized pro-
tein (FN1302) and aspartate aminotransferase (FN1152) were
among the increased proteins. On the other hand, different binding
proteins (FN1423, FN0820, FN0472, FN0652, FN1170, FN0512,
FN0278, FN1812), monosaccharide metabolism proteins (FN0262,
FN0652) and oxidoreductases (FN0512, FN0652, FN0820, FN1170,
FN1423, FN1983) were significantly decreased in dual-species EPM.
In P. gingivalis EPM biofilms no proteins showed statistically sig-
nificant difference compared to the dual-species EPM in terms of
the protein LFQ intensities.
3.5. Prediction of EPM-associated proteins with virulence properties
To further characterize the EPM-derived protein datasets, we
performed prediction of virulence factors by cascaded SVMmodule
of the VirulentPred tool. Proteins with high score in virulence po-
tential (Table 3) were mainly uncharacterized proteins and hypo-
thetical cytosolic proteins that need more elaboration on their
function.
Among the P. gingivalis virulence proteins were several fimbriae:
the subunit protein of long FimA fimbria was found in the EPM of
both mono- and dual-species biofilm and the accessory fimbriae
FimCDE and FimDE were found in mono- and dual-species biofilm,
respectively. Lys-gingipain (kgp), hemagglutinin HagA and pepti-
dylarginine deiminase (PGN_0898) are P. gingivalis virulence factors
that were found in the EPM of mono and dual-species biofilms
(Additional file 2: Table S1).
Searching for outer membrane proteins (OMPs) in our dataset
was of particular interest because OMPs are often involved in ad-
hesive properties and binding of F. nucleatum and P. gingivalis. Forty
proteins were predicted by SOSUI-GramN tool as OMPs (21 and 19
from F. nucleatum and P. gingivalis, respectively) (Additional file 2:
Table S1). In addition, we used the BOMP web-based tool for the
prediction of OMPs containing integral b-barrel domains. Fourteen
proteins in the dual-species biofilm matrix, 18 in the F. nucleatum
biofilm matrix and 10 in the P. gingivalis biofilm matrix were pre-
dicted as integral b-barrel outer membrane proteins (Table 4). The
OMVs predictions by the SOSUI-GramN and BOMP tools overlapped
for 14 proteins. However, in 11 and 3 cases the SOSUI-GramN
suggested extracellular and cytoplasmic localization, respectively,
while the BOMP indicated that the respective proteins contain in-
tegral b-barrel domain (Table 4).
4. Discussion
In this study we used high-resolution proteomics to identify and
quantify proteins in the EPM of F. nucleatum and P. gingivalis when
grown in mono- or dual-species biofilms. The two selected strains
are found in the normal flora of the mouth, they have documented
role in the periodontal disease, and their genomes have been
sequenced [32,33]. The bacteria were cultured for four days which
gave a mature biofilm with adequate amount of the EPM [13], and
also had a minimal effect on the number of viable cells in the
biofilms (Table 1). To identify EPM associated proteins of
F. nucleatum and P. gingivalis biofilms, the bacteria were grown in
cell culture flasks on a plastic surface both individually and
together, an approach that allowed for investigation of possible
interactions between the two species at the protein level. Initially,
extracellular matrix was isolated from each biofilm by mechanical
shearing and filtration through membranes that removed cellular
debris and whole cell contaminants. We avoided sonication and
chemical treatment to reduce contaminationwith cellular proteins.
This protocol has been previously validated and confirmed that it
does not provoke cellular lysis [19], and a similar procedure with
minor modifications has been used to study the matrix proteins in
Pseudomonas aeruginosa biofilm [34].
The number of identified proteins was similar to other studies
on EPMs of bacterial biofilms, which reported between 150 and 270
EPM proteins [34,35]. Reasons for the high number of protein
identifications in the EPM of F. nucleatum (542 proteins), when
compared to the numbers derived from P. gingivalis and dual-
species EPMs (93 and 280 proteins, respectively), are not entirely
clear. The high number of F. nucleatum proteins in the biofilm
matrix could be caused bymore intensive cell lysis, when compared
to P. gingivalis. However, only moderate changes in the number of
viable cells were observed in the growth period of four days
(Table 1). A possible mechanism behind cell lysis might be pro-
grammed cell death (PCD). F. nucleatum has Cid/Lrg homologues of
so-called holins, small membrane proteins responsible for PCD in
the bacteria, whose role is mainly associated with permeabilisation
of the cytoplasmic membrane andwith concomitant protein export
[36,37]. For example, in Staphylococcus aureus CidA contributes to
biofilm adherence both in vitro and in vivo by affecting cell lysis and
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the release of genomic DNA [38,39]. The murein hydrolase exporter
(FN0467) and murein hydrolase export regulator (FN1531), which
are the holins of F. nucleatum, are both found in the proteome of
F. nucleatumwhen grown in biofilm or under planktonic conditions
[37].
Moreover, a high number of nucleotide-binding proteins in the
Fig. 3. Quantitative analysis of the identified EPM proteins. A) Boxplots showing distribution of log2 transformed LFQ intensities among 471 F. nucleatum (Fn), 39 P. gingivalis (Pg)
and 114 (FnPg) proteins in the mono- and dual-species EPMs, red marks indicate the maximum outliers. B) Histograms showing the distribution of averaged log2LFQ intensities
across the samples, the vertical axis shows the counts of identified proteins. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
Table 2
Top abundant proteins identified in the mono- and dual-species EPM of F. nucleatum and P. gingivalis.
Accession Gene Name Protein Description Major Function Log2 LFQ
Top 10 in F. nucleatum EPM
Q8RG24 FN0495 Acetyl-CoA acetyltransferase acyltransferase 33.57
Q8R6D3 FN1983 Alkyl hydroperoxide reductase C22 protein oxidoreductase 33.45
Q8REM0 FN1079 Neutrophil-activating protein A virulence factor 33.42
Q8RHQ6 FN1943 Tryptophanase lyase 33.27
Q8RG30 FN0488 Glutamate dehydrogenase oxidoreductase 33.16
Q8RDT4 FN1419 Methionine gamma-lyase lyase 32.67
Q8RES5 FN1019 3-hydroxybutyryl-CoA dehydrogenase oxidoreductase 32.36
Q8RI55 Eno Enolase phosphopyruvate hydratase 32.34
Q8RG46 FN0472 Flavodoxin electron-transfer protein 31.70
Q8RHM6 Tpl Tyrosine phenol-lyase lyase 31.57
Top 5 in P. gingivalis EPM
B2RKJ1 gdh NAD-specific glutamate dehydrogenase oxidoreductase 28.90
B2RLK2 kgp Lys-gingipain protease/virulence factor 28.06
B2RJ88 PGN_0914 Peptidase M24 family hydrolase 25.11
B2RIQ1 PGN_0727 4-hydroxybutyryl-CoA dehydratase oxidoreductase 24.9
B2RKQ8 PGN_1434 Aminoacyl-histidine dipeptidase proteolysis 24.91
Top 5 in dual-species EPM
Q8RG30 FN0488 Glutamate dehydrogenase oxidoreductase 33.80
Q8RG24 FN0495 Acetyl-CoA acetyltransferase transferase 32.36
Q8RE27 FN1302 Uncharacterized protein unknown 32.31
B2RKJ1 gdh NAD-specific glutamate dehydrogenase oxidoreductase 29.78
Q8REM0 FN1079 Neutrophil-activating protein A virulence factor 29.40
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EPMs of F. nucleatum and the dual species biofilms coincide with
our previous results that showed DNA as a major component in the
biofilm matrix [13], and further support occurrence of cell lysis
during biofilm formation.
P. gingivalis is an asaccharolytic microorganism (i.e. unable to
metabolize carbohydrates) while F. nucleatum is able to utilize
amino acids, peptides and sugars [40]. Accordingly, we noticed that
most of the detected metabolic pathways in P. gingivalis EPM had a
role in amino acid metabolism [41]. This finding and generally high
percentage of other metabolic enzymes detected in the EPMs of
both F. nucleatum and the dual species biofilms, are indications of
the putative role of thematrix as an external source of nutrition and
energy production as previously predicted in other bacterial bio-
films [6,42].
Studies on these two organisms found evidence of physiological
support between the species [43,44]. F. nucleatum is a moderate
anaerobe, however, its ability to adapt to and reduce an oxygenated
environment is extremely high [43]. On the other hand, P. gingivalis
cannot survive in an aerated environment above 6% O2when grown
as a monoculture, but when grown as a co-culture with
F. nucleatum, P. gingivalis can survive O2 levels of up to 20% [43].
Proteins associated with oxidative stress were abundant in the
matrix of the studied biofilms, similar to findings described in a
study of the P. aeruginosa EPM [34]. Oxidative stress response
proteins were also previously shown to be up-regulated in the
biofilms of Tannerella forsythia [45] and Campylobacter jejuni [46],
when compared to planktonic growth. It has been suggested that
mixed species biofilms enhance the production of oxidative stress
proteins because the more strict anaerobes are dependent on ox-
ygen tolerant bacteria [47].
The two-species biofilm model used in this study represents a
limited example since periodontal diseases develop in a poly-
microbial environment. Although biofilm models with multiple
bacterial species could represent more closely in vivo condition
[48], such models are difficult to control and manipulate. Biofilm
model with only two bacteria, such as the F. nucleatum - P. gingivalis
model, is more straightforward for interpreting possible in-
teractions between the two species. The proteomic analysis showed
differential production of 22 F. nucleatum proteins between the
mono and dual-species EPMs (Fig. 4) and 11 proteins were detected
Fig. 4. Differentially expressed F. nucleatum proteins in mono- and dual-species EPMs. Volcano plot shows results of two-sample t-test with p-value % 0.05, which was per-
formed on log2 LFQ intensities of 36 proteins common for the EPMs of mono- and dual-species biofilms. Changes in relative abundances were detected for 22 F. nucleatum proteins
(shown with the gene name).
Table 3
Top scored virulence-related proteins identified in the mono- and dual-species EPM of F. nucleatum and P. gingivalis, as predicted by VirulentPred web-based tool.
Accession Gene Name Protein Description Scorea
Top 10 in F. nucleatum EPM
Q8RHI8 FN2034 Protein YicC 1.15
Q8RGA1 FN0407 Uncharacterized protein 1.14
Q8RGH5 FN0320 Hypothetical cytosolic protein 1.14
Q8RFA8 kdsB 3-deoxy-manno-octulosonate cytidylyltransferase 1.14
Q8RH51 FN0062 Hypothetical cytosolic protein 1.13
Q8RI03 FN1835 Uncharacterized protein 1.13
Q8RG53 FN0465 Uncharacterized protein 1.13
Q8RDV3 glsA Glutaminase 1.13
Q8RH86 FN0024 Hypothetical exported 24-amino acid repeat protein 1.13
Q8RHV9 FN1884 Uncharacterized protein 1.12
Top 5 in P. gingivalis EPM
B2RGY4 PGN_0110 Putative uncharacterized protein 1.15
B2RLK7 hagA Hemagglutinin protein HagA 1.11
B2RIL7 PGN_0693 Putative uncharacterized protein 1.05
B2RH58 fimD Minor component FimD 1.04
B2RK12 PGN_1188 Putative uncharacterized protein 1.03
Top 5 in dual species EPM
B2RGY4 PGN_0110 Putative uncharacterized protein 1.15
Q8RG53 FN0465 Uncharacterized protein 1.13
B2RLK7 hagA Hemagglutinin protein HagA 1.11
Q8R614 FN1387 Metal dependent hydrolase 1.11
Q8RFM6 FN0666 Uncharacterized protein 1.11
a Support Vector Machine (SVM) score. The protein is virulent if the score &0.
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only in the dual-species EPM (additional file 1, Table S4). These
results indicate that the two species specifically influence each
other at the protein level, further supporting synergistic action
between these two oral pathogens [43,44].
Among the most abundant proteins identified in the EPM were
molecular chaperons. Previously, typical cytosolic proteins GroEL
and DnaK were described to be associated with membranes and
extracellular fractions of F. nucleatum [49]. Targeting GroEL could
represent an antimicrobial strategy with broad-spectrum applica-
tion, and recently a high-throughput screening effort to discover
chemically and structurally diverse inhibitors of GroEL/GroES has
been undertaken [50]. Moreover, P. gingivalis GroEL immunization
was reported to significantly reduce the levels of alveolar bone loss
induced by multiple periodontopathic bacteria in an animal model
[51]. Finally, the presence of oxidoreductases and various chap-
erone proteins in the EPM of oral bacteria biofilms is not only of
interest regarding periodontal diseases, but also for possible asso-
ciations of bacterial biofilms with systemic inflammatory and
autoimmune diseases [52e54].
Twenty-five of the proteins detected in the EPM of P. gingivalis
biofilm were previously identified as outer membrane vesicles
(OMVs) proteins [55] (Additional file 2: Table S1). P. gingivalis is able
to specifically concentrate and release a large number of its viru-
lence factors into the environment in the form of OMVs, and these
vesicles have been linked to biofilm formation for example in
Helicobacter pylori [56]. Our results show that P. gingivalis OMVs
proteins represent a significant portion of the EMP proteome and
OMVs are therefore likely contributors to the biofilm development.
An example of P. gingivalis OMVs protein identified both in mono-
and dual-species EPMs was hemagglutinin HagA, a surface protein
that can function as an adhesin attaching bacteria to the host cells
[57]. We identified several other P. gingivalis virulence proteins in
the biofilmmatrix, such as fimbriae that are key factors in adhesion
of the bacterial cells to the host tissue, its colonization and invasion
of host cell membranes [58]. Another virulence protein that con-
tributes to the destruction of periodontal tissues is Lys-gingipain
(kgp), and in our dataset it was one of the most abundant
P. gingivalis EPM proteins (Table 2 and Additional file 4: Table S3).
Table 4
b-barrel integral outer membrane proteins identified in the mono- and dual-species EPM of F. nucleatum and P. gingivalis, as predicted by BOMP web-based tool.
Accession Gene Name Description BOMP Categorya Known as OMP Prediction by SOSUI-GramNb
F. nucleatum EPM
Q8REA9 FN1200 Uncharacterized protein 5 OM
Q8RIP5 FN1526 Fusobacterium outer membrane protein family 5 [32] EC
Q8RHY1 FN1859 Major outer membrane protein FomA 4 [32,69] OM
Q8R608 FN1426 Serine protease 4 OM
Q8RFV3 FN0579 Hypothetical cytosolic protein 3 OM
Q8RI47 FN1787 Tetratricopeptide repeat family protein 3 C
Q8RF62 glgB 1,4-alpha-glucan branching enzyme GlgB 3 C
Q8RFS7 FN0610 Uncharacterized protein 3 EC
Q8R6D6 FN1950 Serine protease 2 OM
Q8RE26 ssb Single-stranded DNA-binding protein 2 EC
Q8RH76 FN0034 Uncharacterized protein 1 EC
Q8RFG5 FN0735 Cell surface protein 1 OM
Q8RHC7 FN2110 Hypothetical exported 24-amino acid repeat protein 1 EC
Q8RHM8 FN1986 Uncharacterized protein 1 EC
Q8RHV1 FN1893 Fusobacterium outer membrane protein family 1 [32] EC
Q8RHH1 FN2058 Fusobacterium outer membrane protein family 1 [32] EC
Q8RE33 FN1296 Uncharacterized protein 1 EC
Q8RGN9 FN0247 Hypothetical cytosolic protein 1 C
P. gingivalis EPM
B2RLL8 PGN_1744 Putative uncharacterized protein 4 OM
B2RLU2 PGN_1818 Putative uncharacterized protein 3 OM
B2RLK7 hagA Hemagglutinin protein HagA 3 EC
B2RLK2 kgp Lys-gingipain 3 [70] OM
B2RHG7 ragA Receptor antigen A 3 [70] OM
B2RGP7 porV Por secretion system protein porV (Pg27, lptO) 1 OM
B2RKP0 PGN_1416 Probable lysyl endopeptidase 1 OM
B2RM93 rgpA Arginine-specific cysteine proteinase RgpA 1 [70] OM
B2RIW9 PGN_0795 Putative uncharacterized protein 1 OM
B2RH26 PGN_0152 Immunoreactive 61 kDa antigen 1 EC
Dual species EPM
Derived from F. nucleatum
Q8REA9 FN1200 Uncharacterized protein 5 OM
Q8RIP5 FN1526 Fusobacterium outer membrane protein family 5 [32] EC
Q8R608 FN1426 Serine protease 4 OM
Q8RHY1 FN1859 Major outer membrane protein FomA 4 [32,69] OM
Q8RFV3 FN0579 Hypothetical cytosolic protein 3 OM
Q8RE33 FN1296 Uncharacterized protein 1 EC
Q8RHH1 FN2058 Fusobacterium outer membrane protein 1 [32] EC
Derived from P. gingivalis
B2RLL8 PGN_1744 Putative uncharacterized protein 4 OM
B2RHG7 ragA Receptor antigen A 3 [70] OM
B2RLK2 kgp Lys-gingipain 3 [70] OM
B2RLK7 hagA Hemagglutinin protein HagA 3 EC
B2RIW9 PGN_0795 Putative uncharacterized protein 1 OM
B2RKP0 PGN_1416 Probable lysyl endopeptidase 1 OM
B2RM93 rgpA Arginine-specific cysteine proteinase RgpA 1 [70] OM
a BOMP Category 1 is the least reliable prediction while category 5 is the most reliable prediction of integral b-barrel domains.
b OM: outer membrane, EC: extracellular, C: cytoplasmic.
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Gingipains degrade collagen and fibronectin and inhibit in-
teractions between host cells and the extracellular matrix. In
addition, they degrade various cytokines, resulting in a disruption
of the host cytokine network [58]. Another P. gingivalis protein
identified both in mono- and dual-species EPM was PGN_0898, a
bacterial peptidylarginine deiminase (PAD) (Additional file 2:
Table S1). It gives P. gingivalis a unique ability to citrullinate proteins
[59]. Citrullinated bacterial and host peptides may cause an auto-
immune response in rheumatoid arthritis [59,60].
Sequence-based prediction of the proteins subcellular localiza-
tion is an important part of the identified proteome description and
an essential step in the search for novel vaccine or drug targets
[61,62]. Our data provided evidence that the matrix proteome
consists of secreted proteins, proteins from cell debris, and OMPs.
The prediction of OMPs in this study was of particular importance
due to their involvement in adhesive properties and coaggregation
of F. nucleatum and P. gingivalis with other bacteria, as well as
attachment to host cells. The latter interaction has significance both
in the pathogenesis of infection and in the immune response of the
host [62]. The SOSUI-Gram and BOMP tools identified 40 and 42
OMPs, respectively, and there was variation in the prediction out-
comes of the two bioinformatics methods. This observation illus-
trates that the use of several bioinformatics methods is both
beneficial and necessary, and cross-referencing with available
literature should complement the importance of the predictions.
The BOMP tool specifically predict membrane proteins containing
b-barrel integral domains, which can havemany different functions
including enzymatic, transport and structural support [63]. An
example of such OMP is FomA (FN1859) that was identified in both
mono- and dual-species EPM (Table 4). It is a nonspecific porin
which acts as a virulence factor, and a major antigen of F. nucleatum
[64,65] that plays a role in binding to P. gingivalis [66]. FomA of
F. nucleatum represents a potential target protein for the prevention
of bacterial co-aggregation by vaccination [66,67]. Other detected
putative F. nucleatum virulence factors were auto-transporter
fusobacterium outer membrane protein (FN1526) and serine pro-
tease (FN1426). Both proteins are involved in protein secretion
pathways [37], and the latter has peptidase and hydrolase activity,
which allows degradation of fibronectins, fibrinogens and colla-
gens. The capacity of F. nucleatum to degrade proteins of the
extracellular matrix of host connective tissues has been described
as a significant contributor to invasion of the gingival tissue and
subsequent damage of periodontal tissues [37,68].
5. Conclusion
To our knowledge this is the first study to explore proteins in the
extracellular matrix of biofilms formed by the oral bacteria
F. nucleatum and P. gingivalis. Potential virulence proteins, outer
membrane proteins and various binding proteins (DNA-binding,
ATP-binding, and metal ion-binding) were among the abundant
proteins identified in the biofilm EPM. These proteins represent
potential candidates to be targeted for the inhibition of biofilm
development. Furthermore, identification and quantification of the
proteins provides a molecular basis for further revealing their role
in the formation of EPM and might contribute to an understanding
of F. nucleatum and P. gingivalis role in the development of peri-
odontal and systemic diseases.
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